Podcasts about chief science

Dr. Aristo Vojdani discusses Precision Environmental Medicine with moderator Dr. Ben Weitz at the Functional Medicine Discussion Group meeting on February 27, 2025.   [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]    Podcast Highlights     Dr. Aristo Vojdani is Father of Functional Immunology and he has dedicated his life's research to helping us figure out what are the triggers for autoimmune diseases and many of the tests he has developed for Cyrex Labs are focused on this.  Dr. Vojdani has a PhD in microbiology and immunology and he has authored over 200 scientific papers published in peer reviewed journals. Dr. Vojdani is the co-owner of Immunosciences Lab in Los Angeles, which offers testing for various types of infections, including Lyme Disease. He is the Chief Science advisor for Cyrex Labs, whom he has developed all of the testing for, including the Lymphocyte Map test, Array 2 for Leaky Gut, and Array 5, The Multiple Autoimmune Reactivity Panel.  Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

Are you wondering how to pivot from academia to the neurotech industry without starting from scratch? Many assume that moving from a PhD to industry means leaving much of their academic experience behind, but that's not necessarily the case. Welcome to this episode of Neurocareers: Doing the Impossible!, where we uncover how advanced academic skills can be a powerful asset in the neurotech sector. Today, we're honored to have Dr. Mustafa S. Hamada, Chief Science and Product Officer at Mendi Innovations in Sweden, share invaluable insights on leveraging PhD skills to break into and excel in neurotechnology. Dr. Hamada, a trailblazer in integrating neuroscience with product innovation, will guide us through how we can translate academic expertise into industry success. He'll reveal what industry employers are looking for during interviews, discuss the benefits of being a generalist versus a specialist, and provide tips on navigating the job market with your unique skills. Moreover, we'll dive into the strategic choices that can shape your career path: selecting the right company size, the importance of mentorship, and working in start-up environments. Dr. Hamada will also touch on the impact of AI in neurotech, compare the job markets in Europe and the US, and forecast the future of the industry. If you're eager to learn how your PhD can open doors in the neurotech field, and you want to know what it takes to stand out to employers and thrive in this dynamic industry, then tune into Dr. Hamada's expert advice and personal journey. Transform your academic achievements into your industry advantage with insights from a leading expert in neurotech. Let's discover how to leverage your PhD for success in the fast-evolving world of neurotechnology together! About the Podcast Guest: Dr. Mustafa S. Hamada is the Chief Science and Product Officer at Mendi Innovations, a neurotechnology startup in Sweden. Dr. Hamada drives the integration of advanced neuroscience into innovative product development, focusing on neurotechnology, behavioral design, and AI to enhance brain health solutions. He was also a recipient of the Grand Prize for Engineering in Innovation 2024. Work email: mustafa@mendi.io LinkedIn: www.linkedin.com/in/mustafashamada   About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Send us a textDr. Nina Siragusa, Ph.D., MBA, is the Strategy, Business, and Data & Digital Lead within the global R&D organization of Merck Healthcare KGaA, Darmstadt, Germany. In this role, she leads strategic projects, manages business operations, and drives digital transformation.Previously, she served as Chief of Staff to Dr. Laura Matz, Chief Science and Technology Officer at Merck KGaA, Darmstadt, Germany. As part of the Science and Technology Office Leadership Team, she was responsible for fostering cross-sectoral collaboration, innovation, and digitalization across Merck's three business sectors. She also spearheaded the company's efforts in Bioconvergence, a multidisciplinary approach that synergizes biology, engineering, data, and digitalization. This initiative promises groundbreaking advancements in healthcare and the life sciences, heralding a new era of scientific collaboration for a healthier, more sustainable future.Prior to that, Dr. Siragusa contributed to corporate innovation in several leadership roles:• As Biotechnology Lead of a synthetic biology innovation project,• As Senior Manager, responsible for creating strategic alignment and building high-performing teams, and• As Associate Director, focusing on sourcing innovative ideas to generate new business opportunities.Dr. Siragusa earned her Ph.D. in Biology from the University of Tuebingen, Germany, and conducted research in Europe and the USA, including at Yale University, before joining Merck KGaA, Darmstadt, Germany in 2016.In 2024, she completed an MBA in Digital Transformation Management with a focus on Digital Leadership at Goethe Business School, Frankfurt, Germany.Dr. Siragusa is also the lead author of the recently published book, Bioconvergence Revolution: Challenges and Opportunities in Research Productivity. You can find it here: https://link.springer.com/book/10.1007/978-3-031-61593-1Home Page Merck KGaA Darmstadt, Germany - https://www.emdgroup.com/en#NinaSiragusa #EMDGroup #MerckKGaADarmstadtGermany #Bioconvergence #Ethics #Collaboration #Fungi #NaturalProducts #Biomimicry #AI #DrugDiscovery #Bioremediation #TranslationalMedicine #SmartManufacturing #DigitalTwins #Supermind #MIT #ResearchFunding #Israel #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Dr. Bruce Strober, MD, PhD, dermatologist and JPPA Editor-in-Chief, and Guy Eakin, PhD, Chief Science and Medical Officer at the NPF discuss the Journal of Psoriasis and Psoriatic Arthritis path to indexing and what it means for the research community moving forward.    This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

The body is not a machine, nor a temple. It is an infinitely complex and unique system, and according to Dr. Ralph Esposito, Chief Science & Nutrition Officer at AG1, it's one we know less about than we think. Dr. Ralph is a naturopathic physician and gut health expert, and he joins host Casey Bannon to discuss the science behind whole-body wellness. Rather than broad-spectrum advice, Dr. Ralph offers approachable insights into how your body works. This information-rich chat touches on the significance of sleep, the dangers in some diet trends, the proper way to fuel your brain and body and much more. Plus, you'll learn the science-backed reason that your favorite Tour pros are munching on the same food at the same point in every round. Get 10 free AG1travel packs when you subscribe: https://drinkag1.com/event/bts24 Gift the #1 Ball in Golf: https://www.titleist.com/ Subscribe to The Golfer's Journal: https://www.golfersjournal.com/ All Mind Game episodes: https://www.golfersjournal.com/category/mind-game-podcast/

The Trump-Vance transition team and the Biden administration signed a memorandum of understanding last week formally kicking off the process to hand over executive power — though the Trump team has decided not to accept some of the government's available resources, including tech and information security provided by the General Services Administration. The transition team will reportedly run as a “self-sufficient organization” with existing security and information protections already built-in, utilizing private funding, according to the press release from the Trump transition team. That includes not using technology or buildings provided by the General Services Administration as part of the transition resources the agency is authorized and appropriated to provide. The Trump team said it “already has existing security and information protections built in, which means we will not require additional government and bureaucratic oversight.” The Department of Justice's Office of the Inspector General called out the agency's lack of an updated public strategy for artificial intelligence and underscored the need to be proactive in a report on its management and performance challenges last week. The comments came as part of the OIG's determination that maintaining cybersecurity and keeping up with emerging technologies, such as AI, were among the top challenges for the DOJ. For AI specifically, the report underscored how long ago the department's public AI strategy was released. The OIG's office said in the report: “While the Department has made efforts to adapt to the change in the technological landscape, such as hiring the Department's first Chief Science and Technology Advisor and Chief AI Officer, the most recent publicly issued strategy on AI from the Department—which outlines an AI adoption and coordination strategy with DOJ component responsibilities—is from 2020.” The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast  on Apple Podcasts, Soundcloud, Spotify and YouTube.

Dr. David Dodick is a notable neurologist and the Chief Science and Medical Officer of Atria. He joins Martha to discuss the latest research about lifestyle interventions that help reduce cognitive decline, actionable ways to optimize your brain health, and when to be worried. He also shares tips for stroke prevention and explains why sleep is really the most important thing you can do for the body.See omnystudio.com/listener for privacy information.

Today I'm joined by Jayshree Seth, Corporate Scientist and Chief Science Advocate at 3M, who discusses our relationship with science and engineering and the important role it plays in innovation, problem solving, and professional and personal growth.   Show notes and further links:   Jayshree's 3rd book in the ‘Heart of Science' series, ‘The Heart of Science: Engineering Blueprint': https://a.co/d/7DUD3lv Fast Company article with Prof Amy Edmondson: https://www.fastcompany.com/91012097/4-big-morale-busting-communication-mistakes-leaders-should-stop-making Fast Company article with Prof Rita McGrath: https://www.fastcompany.com/90954158/a-guide-for-managing-innovation-4-big-mistakes-technologists-wish-their-business-leaders-would-quit-making Drucker Forum blog article on sustainable innovation: https://www.druckerforum.org/blog/the-3-cs-of-sustainable-innovationby-jayshree-seth/     Sponsored by https://www.b2bframeworks.com Brought to you in partnership with https://awardsinternational.com 

A signficant situation vacant is causing concern in the science world and beyond. The government won't say whether it's keeping role of Prime Minister's Chief science advisor; a job that has been empty since July. That's despite the coalition agreement saying "decisions will be based on data and evidence."Among other things the chief science advisor provides advice on specific topics to the PM and Ministers and information in a crisis like, the covid pandemic. However, past advice from Prime Ministerial science advisors on dealing with gangs, a rising prison population , and boot camps has run contrary to a number of policies the current government's adopted. The budget for the office has also been cut by half a million dollars. Simon Kingham was Chief Science advisor to the NZTA, up until May this year and spoke to Lisa Owen.

In this episode, Dom Hawes interviews cognitive neuroscientist Carmen Simon, uncovering how brain science can help marketers ensure their content is remembered. Carmen highlights the importance of focusing on distinctiveness and emotion to make sure your audience recalls the most crucial parts of your message. By understanding how the brain processes and retains information, marketers can begin crafting content that truly sticks, helping brands stand out in today's crowded digital space.Key points:Why distinctiveness helps capture and keep audience attention.How emotions play a key role in enhancing memory retention.The practical application of neuroscience tools like EEGs and eye-tracking in content strategy.Defining your "10% message" to ensure you focus on what matters most to your audience.Catch the full episode for more on how neuroscience can transform your marketing approach.Competition time!

In this episode, Dom Hawes interviews cognitive neuroscientist Carmen Simon, uncovering how brain science can help marketers ensure their content is remembered. Carmen highlights the importance of focusing on distinctiveness and emotion to make sure your audience recalls the most crucial parts of your message. By understanding how the brain processes and retains information, marketers can begin crafting content that truly sticks, helping brands stand out in today's crowded digital space.Key points:Why distinctiveness helps capture and keep audience attention.How emotions play a key role in enhancing memory retention.The practical application of neuroscience tools like EEGs and eye-tracking in content strategy.Defining your "10% message" to ensure you focus on what matters most to your audience.Catch the full episode for more on how neuroscience can transform your marketing approach.Competition time!

Dr. Hoffman continues his conversation with molecular biologist Pita Navarro, co-founder and Chief Science officer at Evvy, pioneering the research to improve diagnostics and treatments for underserved conditions in the female body.

Dr. Joe Parker is our guest. Listen to what led to his prison sentence. Dr. Parker's Bio Dr. Joseph Parker's career spans the fields of science, military service, and medical practice. He has used his rare blend of scientific expertise, military leadership, and medical acumen to contribute significantly to the advancement of science and the betterment of human health and safety. He writes as an advocate for physicians and patients and for the humane treatment of those suffering from addiction and the incarcerated. His journey towards this impactful role began with four years of dedicated service in the US Marine Corps, where he earned accolades such as the Meritorious Unit Citation and Good Conduct Medal. His exceptional service led to acceptance into the US Air Force Officer Training School and a subsequent role as a Minuteman II ICBM Commander within US Space Command, earning further recognition, including the Presidential Unit Citation, National Defense Service Medal, and the Air Force Achievement Medal. Transitioning into the medical field, Dr. Parker pursued studies at Mayo Medical School and joined the US Medical Corps, ultimately achieving the rank of Captain. Having personally suffered wrongful convictions gives him a unique perspective on the American justice and prison system, and he has dedicated himself to advocacy for the wrongfully prosecuted. He is currently serving as the Chief Science and Operations Officer at Advanced Research Concepts LLC, a pioneering company dedicated to biomedical research to alleviate pain and addiction, and to the development of innovative solutions for the complex challenges of space travel, including spacecraft propulsion systems, energy storage, radiation shielding, artificial gravity, and space-related medical issues.  He is also active in biomedical research, space science, and the study and treatment of addiction. The information in this podcast is not to be considered medical or legal advice

Omico is leading Australia's largest cancer genomics initiative –giving 23,000 Australians nationwide with advanced or incurable cancers, access to genomic profiling to detect unique genetic variations in their tumours to identify potential matches to new targeted treatments options. It is opening up new treatment pathways, extending lives and attracting more international trials to Australia.Professor David Thomas, renowned for his groundbreaking work in precision oncology, is the founder and Chief Science and Strategy Officer of Omico - the Australian Genomic Cancer Medicine Centre. In this episode, host Caroline Duell speaks with Professor Thomas to find out more about his mission to open up new treatment options for all cancer patients using genomics, the impact of pan tumour therapies on our healthcare system, and why we need to change the way we look at cancer care and cure right now before more people die unnecessarily.

Today we are making nature great again with Rob Waterworth, Co-Founder & Chief Science and Innovation Officer at FLINTpro. The company enables managing and reporting emissions and nature risks across a portfolio. Clients may understand the Scope 1 and 3 emissions liability, deforestation risk, and biodiversity impact of their portfolio and future investment opportunities. The company also assists to navigate evolving disclosure requirements and generate audit-ready reports. Additionally, they help identify emissions reduction and value creation opportunities to reach a client's climate commitments. THE GEOSPATIAL INDEX The Geospatial Index is a comprehensive listing of all publicly traded geospatial businesses worldwide. Why? The industry is growing at ~10% annually. This varies significantly, however, by sub index. For only $58,000 to start, this growth rate is $5,000,000 over a working life. This channel, Bluesky account, newsletter, watchlist and podcast express the view that you are serious about geospatial if you take the view of an investor, venture capitalist or entrepreneur. You are expected to do your own research. This is not a replacement for that. This is not investment advice. Consider it entertainment. NOT THE OPINION OF MY EMPLOYER NOT YOUR FIDUCIARY NOT INVESTMENT ADVICE Bluesky: https://bsky.app/profile/geospatialindex.bsky.social LinkedIn: https://uk.linkedin.com/in/geospatialindex Watchlist: ⁠https://www.tradingview.com/watchlists/123254792/ Newsletter: https://www.geospatial.money/ Podcast: https://open.spotify.com/show/5gpQUsaWxEBpYCnypEdHFC

Join host Lara Birkes as she interviews Robert Waterworth, Co-founder and Chief Science, Policy, and Innovation Officer at FLINTpro. Discover how FLINTpro is revolutionizing the way businesses understand and mitigate their environmental impact through cutting-edge data integration and analytics. Key topics covered: FLINTpro's journey from carbon accounting to comprehensive nature impact assessment; The importance of integrated data approaches in environmental analysis; FLINTpro's key offerings: advanced analytics, insights products, and regulatory risk mapping; How businesses can use FLINTpro to guide environmental strategy and compliance; The future of nature-related data in corporate decision-making. Whether you're a sustainability professional, business leader, or simply interested in the intersection of technology and environmental protection, this episode offers valuable insights into the tools shaping our understanding of business impacts on nature. learn more: https://www.flintpro.com/ #NatureIS #FLINTpro #Sustainability #EnvironmentalImpact #ClimateChange #Biodiversity # About Better Worlds We believe that the digital transformation and related technologies are revolutionizing the very nature of the way we live and who we are. Done right, these innovations can help lead us to a better world. We're here to bring together the people and the tools to help you build it. One key focus of our mission is to explore how the innovations of Web3, Ai, and Quantum Computing can help to sustain the natural world and build greater efficiencies to grow our shared prosperity. We believe in creating a collaborative, inclusive, and sustainable community to explore innovative solutions. Solutions that will contribute to achieving bioregional and global prosperity by integrating our three interconnected worlds: the natural world, the human-made physical world, and emerging technologies. @BetterWorlds seeks to explore alternative viewpoints through media, international conferences, symposia, essays and hack-a-thons that encourage and support the development of innovative solutions. Visit our website- https://www.betterworlds.com/ Follow for more updates https://www.linkedin.com/company/betterworlds/ https://twitter.com/onemetaworld

Op Instagram wordt massaal een afbeelding gedeeld met de tekst "All eyes on Rafah". De foto over de stad in de Gazastrook is inmiddels door 42 miljoen mensen geplaatst. Nooit eerder werd een AI-gegenereerde afbeelding met een activistisch doel zo veel gedeeld. Een unieke situatie, zegt Michiel Jurrjens in de Tech Update.Omdat de "All eyes on Rafah"-leus in de afbeelding zelf verwerkt is, ontglipt deze de moderatie van Instagram-moederbedrijf Meta. Berichten over de oorlog in de Gazastrook zijn niet verboden op de platforms van Meta, maar worden slechts beperkt getoond. Verder in de Tech Update: De Algemene Inlichtingen- en Veiligheidsdienst (AIVD) kondigt vandaag een nieuw op te richten Chief Science & Technology Office aan. "De snelheid waarmee technologische ontwikkelingen zich voltrekken dwingt ons om proactief zijn. Daar is een goede visie en een gecoördineerde aanpak voor nodig", zegt directeur-generaal Erik Akerboom van de AIVD.  Barista's van Starbucks klagen over onderbezetting en wijten die aan een nieuw algoritme, meldt Bloomberg. Dat systeem gaat uit van orderprognoses en productbeschikbaarheid, maar houdt volgens de werknemers onvoldoende rekening met het toenemende aantal speciale wensen van klanten, zoals extra espresso of koud schuim. Het algoritme onderschat daardoor hoe veel personeel er nodig is. Klanten moeten daardoor steeds langer wachten, zeggen de werknemers. See omnystudio.com/listener for privacy information.

This week, our Chief Science Officers from Dow High talk about their action plans and the overall responsibilities of a CSO. Sahiba Kaur (Junior), and Preston Komara (Freshman) tell us their story and how they embraced their roles. Record Date 2/16/2024 Release Date 5/23/2024 Scheduled Guests Sahiba Kaur Preston Komara Host and Producer - AJ Hoffman Equipment Tech and Producer - Abby Young Video Podcast https://youtu.be/eWkTFv0DB7Q

This episode of the Flow Radio podcast features Dr. Jef J. J. Van den Hout, associate researcher at the Eindhoven University of Technology and the Erasmus University Rotterdam, the founder of Flow Concepts, and one of the world's foremost experts on flow in teams. Dr. van den Hout joins Flow Research Collective Chief of Staff Ryan Wickes and Chief Science officer Dr. Michael Mannino to talk about how leaders and teams can spark flow and optimize collaboration in the workplace. In This Episode: 0:00 Introduction 01:28 Team Flow vs. Individual Flow 04:19 The Importance of Mutual Accountability 10:12 The Role of Context in Team Flow 15:36 The Default Mode Network in Team Flow 19:39 Facilitating Team Flow Conversations 22:27 Barriers to Team Flow 27:58 The Impact of Team Flow on Individual Happiness 35:05 Constructive Criticism and Team Flow 42:07 The Flow Cycle in Individual and Team Flow 43:52 The Future of Team Flow Research About The Guest: Dr. Jef van den Hout, PDEng, has earned his Ph.D. with a focus on understanding and measuring team flow. He applies this knowledge to enhance team performance in professional settings. As the creator of Flow Concepts, Jef leads efforts to simplify complex team interactions and foster exceptional outcomes. He's an associate researcher with the Eindhoven University of Technology and the Erasmus University Rotterdam. His research spans several key areas: flow, team flow, optimal collaboration, sustainable performance, and challenge-based learning environments such as innovation ecosystems and professional learning communities. Jef is driven by a clear mission: to connect scientific research with real-world practice. He shares, “I find it fascinating to unravel climates for optimal collaboration and moments of team flow. Especially, if the ambitions could lead to something just beautiful, something unusually good, or something completely innovative! ” Episode Resources: Website: https://flowconcepts.nl/ LinkedIn: https://www.linkedin.com/in/jefvandenhout/ X: https://twitter.com/jefvandenhout Facebook: https://www.facebook.com/jef.vandenhout Flow Radio Is Presented By Flow Research Collective Are you an entrepreneur, a leader, or a knowledge worker, who wants to harness the power of flow so you can get more done in less time with greater ease and accomplish your boldest professional goals faster? If the answer is yes, then our peak-performance training Zero To Dangerous may be a good fit for you. Flow Research Collective is a leading neuroscience research and training company. If you're interested in learning the science-backed techniques we used to train top executives at Facebook, Audi and even the Navy SEALs, click the link here: ⁠https://www.flowresearchcollective.com/zero-to-dangerous/overview⁠ Follow Flow Research Collective: YouTube: ⁠https://www.youtube.com/@flowresearchcollective⁠ Instagram: ⁠https://www.instagram.com/flowresearchcollective⁠ LinkedIn: ⁠https://www.linkedin.com/company/flowresearchcollective⁠ X: ⁠https://twitter.com/thefrc_official⁠ Facebook: ⁠https://www.facebook.com/flowresearchcollective⁠ Spotify: ⁠https://open.spotify.com/show/6RQY0d5rdlEiinHEtfWy6A⁠ Website: ⁠https://www.flowresearchcollective.com⁠ Flow Research Collective was founded by Steven Kotler, one of the world's leading experts on human peak performance. He is an award-winning journalist and author with over ten bestselling books.

In this podcast episode, Rhea and I host Seth B. Darling, Argonne's Chief Science and Technology Officer, discussing his journey from chemistry to the water sciences, with a special focus on block copolymers. The conversation zeroes in on the critical nexus between water and energy, emphasizing the urgent of water reuse and the untapped potential of wastewater as a source for nutrients and rare earth elements. Darling's insights highlighted the necessity for scientific research to be guided towards real-world applicability, stressing on life cycle analysis to ensure the viability and sustainability of water technologies. Key discussions include advancing membrane technologies to resist fouling and deploying sensors for enhanced water treatment. The episode advocates for research directed at scalable and sustainable solutions, aiming to catalyze action towards more effective water resource management.

On this week's episode, we feature our Chief Science Officers from Midland High. Brooklyn Jones and Sophia Knarr discuss their positions as CSOs for their school and how this can help them after high school. Jones aims to be a computer scientist, while Knarr discusses her future as an environmental scientist, as well as the recent sustainability fair they brought to life through the process of one of their action items as acting CSOs. View the video version of this podcast here on Youtube https://youtu.be/2JZ3EbSEdh0 Guests: Sophia Knarr Brooklyn Jones MPS Connections Producer and Host: AJ Hoffman Equipment Support: Abby Young

Holden Thorp became Editor-in-Chief of the Science family of journals on 28 October 2019. He came to Science from Washington University, where he was provost from 2013 to 2019 and professor from 2013 to 2023. He is currently a professor at George Washington University and on leave to serve as the Editor-in-Chief at Science.Thorp joined Washington University after spending three decades at the University of North Carolina at Chapel Hill (UNC), where he served as the 10th chancellor from 2008 through 2013.Thorp earned a bachelor of science degree in chemistry from UNC in 1986. He earned a doctorate in chemistry in 1989 at the California Institute of Technology, working with Harry B. Gray on inorganic photochemistry. He completed postdoctoral work at Yale University with Gary W. Brudvig, working on model compounds and reactions for the manganese cluster in the photosynthetic reaction center. He holds an honorary doctor of laws degree from North Carolina Wesleyan College and is a fellow of the American Academy of Arts and Sciences, the National Academy of Inventors, and the American Association for the Advancement of Science. Thorp cofounded Viamet Pharmaceuticals, which developed VIVJOA (oteseconazole), now approved by the FDA and marketed by Mycovia Pharmaceuticals. Thorp is a venture partner at Hatteras Venture Partners, a consultant to Ancora and Urban Impact Advisors, and is on the board of directors of PBS, the College Advising Corps, and Saint Louis University. He serves on the scientific advisory boards of the Yale School of Medicine and the Underwriters' Laboratories Research Institutes.Thorp is the coauthor, with Buck Goldstein, of two books on higher education: Engines of Innovation: The Entrepreneurial University in the Twenty-First Century and Our Higher Calling: Rebuilding the Partnership Between America and its Colleges and Universities, both from UNC Press.Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)

 Best of Business 2023 - Part 4 2023 AZ TRT S04 EP52 (215) 12-31-2023 What We Learned This Week: Alan Payne on the Rise & Fall of Blockbuster Arthur Smith on Reality TV & Sports Trevor Pan of Bidbird on shipping efficiency & container skins Dr. Chuck & Francis of Ally Bio on Cannabis Innovation Chris Owen of J Galt on Commercial Credit Host Matt on Business Assets   Seg. 1 – Clips From: Built to Fail: The Inside Story of Blockbuster's Inevitable Bust w/ Alan Payne AZ TRT S04 EP34 (197) 8-27-2023     What We Learned This Week: ·         Blockbuster started in 1985, and scaled quickly after Wayne Huizenga purchased it in 1987, 10,000 stores at its height, dominant video rental co. ·         Alan Payne instituted the Video Rental model of HEB to the Blockbuster franchises he ran – segmented movies to rent new ones for more ·         Wayne Huizenga was a stellar Founder who built 3 fortune 500 companies – Waste Mgmt, Blockbuster, and Auto Nation ·         Viacom purchased Blockbuster in 1994 for $8.4 billion, and went on to lose 75% of the value over the next decade + ·         Competition was fierce from Hollywood Video, Redbox and then in 1997 by a new DVD rental by mail company called Netflix ·         Netflix scaled into the internet company it always wanted to be with streaming in 2009   Guest: Alan Payne Alan Payne spent thirty-one years in the movie rental business, the last twenty-five of those as a Blockbuster retail franchisee. He took over a small group of Blockbuster stores in 1993 and grew it into one of the largest and most successful chains in the company. He finally closed his last store in 2018, more than eight years after Blockbuster filed for bankruptcy. Book: Built to Fail: The Inside Story of Blockbuster's Inevitable Bust   From the Back Cover Blockbuster was phenomenally successful in its early years and made thousands rich beyond their wildest dreams. But it was consistently outsmarted and outmanaged by smaller companies. And the challenges began earlier than you think--long before Netflix was even an idea in the minds of founders Reed Hastings and Marc Randolph. Blockbuster became one of the most iconic brands in the history of American business, but it cracked at the first sign of a challenge. From its founding, Blockbuster was a company built to fail. Link: HERE     Full Show: HERE   Seg. 2 – Clips From: TV Tales of The Unbreakable Jay Glazer to Creating Competition Shows from American Ninja Warrior to Hell's Kitchen w/ Arthur Smith AZ TRT S04 EP28 (191) 7-16-2023     What We Learned This Week: ·   Jay Glazer's Unbreakable mindset gets him thru ‘the gray' of his daily life, working on his mental health ·   Arthur Smith's describes Reach as striving for our full potential to create amazing things ·   Creation of TV Classics like American Ninja Warrior & Hell's Kitchen   Arthur Smith, the chairman of A. Smith & Co. Productions, is a pioneering veteran of nonfiction television, known for creating and producing some of the longest running unscripted series in history, including Hell's Kitchen and American Ninja Warrior. Smith was honored as one of Variety's “Titans of Unscripted TV” in 2022, inducted into the Realscreen Awards Hall of Fame in 2021, awarded Broadcasting and Cable's “Producer of the Year” in 2020, Nominated for several Emmy Awards, and received dozens of awards, including NAACP Awards, Realscreen Awards, and Critics Choice Awards. Smith embarked on his career in television as a twenty-two-year-old wunderkind, talking his way into sports production at CBC in his native Canada. He quickly distinguished himself as a rising star at the network, where he produced three Olympic Games among countless other high-profile events. At the age of twenty-eight, Smith was named the youngest ever head of CBC Sports. His successful run at the network ended when American broadcasting icon Dick Clark lured him to Hollywood to develop and produce a wide variety of entertainment programming. Then as the head of programming and production at FOX Sports Net, Smith played an instrumental role in the launch and growth of this massive entity, before the biggest reach of his life—the creation of his eponymous production company that has thrived for more than twenty years. He lives in Los Angeles.     Full Show: HERE     Seg. 3 – Clips From: Cannabis Innovation by Ally Biotech w/ Dr. Chuck & Francis - AZ TRT S04 EP36 (199) 9-10-2023                    What We Learned This Week Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products Cannabis is competitive and it's all about the product quality. Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry.       The goal of the company is to adopt the practices of big Pharma and make high grade products. FDA and DEA are actually working together. The DEA treats cannabis like any other Schedule One dangerous drug, like cocaine or heroin. Yet it does not have the same affects, nor addictive qualities. Many pain medication's have very serious side effects as well as the potential for problems with overdosing. Cannabis is a good alternative for pain mgmt.     Guests:   Dr. Chuck Johnson, CSO at Ally Biotech  After earning his BA in Chemistry from Northwestern University and PhD in Analytical Chemistry from Virginia Tech, Dr Chuck refined his craft while working The Procter & Gamble Company, Koch Industries, and Danaher, and expanded his scope of knowledge while working and consulting for DuPont, BATF, FBI, Army Corps of Engineers, Chiyoda Engineering, Toyo Engineering, Japan Gas Company, Yamato, Fisher Scientific, VWR Scientific Products, among others. Chuck brings with him experience with FDA regulatory compliance, LEAN (TPS) principles in Product Development and Manufacturing, competitive market analysis, mergers and acquisitions and technical sales. More recently he has provided consultation services and served as the Chief Science and Operations Officer in the Hemp and Cannabis sectors, including industrial farming, extraction, refining, GMP production, nutraceuticals, and FDA compliance.    Francis Baczek, V.P. of Business Development at Ally Biotech  Francis Baczek serves as Vice President of Business Development at Ally Biotech, a provider of leading-edge bioactive delivery solutions for cannabinoids. Baczek brings significant product development experience in the medical cannabis sector. Since 2013, he has been formulating precision-dosed edibles as lead cannabis chef for Uncle Herb's Health Center, a licensed Arizona operator. Baczek is credite      https://allybiotech.com/about-team/     Full Show: HERE     Efficiency in the Supply Chain by a New Container Invention w/ Trevor Pan of BidBird AZ TRT S04 EP41 (204) 10-15-2023   Things We Learned This Week Malcolm McLean was the inventor of the shipping Container, and a key person in trade & globalization BidBird invented a container skin, a smooth panel for the side to reduce wind resistance & improve fuel efficiency Patent process and Patent Cooperation Treaty to register an invention in foreign countries Building a Prototype and doing a road test with a Truck plus a Container on a race track   Guest: Tevor Pan, BidBird Principal Architect - February 2018 - Present Undergraduate Professional Degree - Landscape Architecture, Colorado State University,  Fort Collins, Colorado 2003 Master Degree - Frank Lloyd Wright School of Architecture, Scottsdale, Arizona 2006   o  Twitter o  LinkedIn     https://bidbird.co/about THE FIRST CONSTRUCTION MARKETPLACE, AT YOUR FINGERTIPS.   Trevor Pan, BidBird Founder & registered Arizona architect.   Spending 21 years as an architect immersed in construction, manufacturing, and design, I've built a unique understanding of the construction industry's constant movements and challenges. I know that construction professionals are exhausted by the RFP game—and the collusion that can come along with it.   I've seen invasive service platforms that trap users into thinking they're a lead generating machine, but then unethically charge them thousands with no quality results.   When I set off to launch BidBird, I wanted to eliminate the red tape and corruption for suppliers, manufacturers, contractors, and building owners. And when my barber approved the irresistible alliteration of the name, BidBird was born.   BidBird is the new way for construction professionals to achieve a constant-but-necessary thing: capture competitive bids for their materials through an efficient process.   At its core, our mission is simple. We connect construction industry professionals around the country through an honest platform that doesn't cost users unreasonable fees, or their dignity.   With its simplicity comes big things. BidBird is an opportunity to beat out the “big guys” by just a penny, equalizing the hunt for businesses around the country.   We strive to combine high-value jobs + the innovation to evolve with construction professionals' needs to transform businesses, one bid at a time.         Full Show: HERE   Seg. 4 – Clips From: Building Commercial Credit w/ Chris Owen of J. Galt AZ TRT S04 EP45 (208) 11-12-2023   Things We Learned This Week J. Galt Helps Small Businesses Optimize Cashflow & Manage Growth Helping Business Owners Access Loans & Credit, Endangering Their Personal Credit & Family Assets Small Business is the backbone of a community, when it thrives, so does the community 3 Types of Credit - Personal, Business & Commercial Credit - Business need to build their Commercial Credit     Guest: Chris Owen  LKIN: HERE Helping Business Owners Access Loans & Credit   Endangering Their Personal Credit & Family Assets When small businesses prosper, then the community also thrives. The passion I have for helping fellow entrepreneurs succeed is something I've fostered my entire life. As an advocate and advisor for small businesses I have seen the challenges they face firsthand. When businesses fail, they leave an average of $80K for the business owner and their family. Knowing these daunting stats, it has become my life's mission to help protect these incredible small businesses that are the bedrock of our economy. Can you imagine what your small business would look like in 12 months if… ✅     You didn't get turned down for the loan, credit card, or line of credit you needed? ✅     Your access to loans and credit didn't impact your personal credit or put your family home at risk? ✅     You had the money you needed to expand and meet new opportunities?   J. Galt: https://www.jgalt.io/cowen     Full Show: HERE     Rethinking What is an Asset AZ TRT S04 EP39 (202) 10-1-2023     What We Learned This Week:   ·         Knowledge as an Asset  ·         Industry You Work in as an Asset   ·         Your Network as an Asset  ·         Leverage as an Asset   ·         Focus as an Asset  ·         Traditional Investment Assets – Appreciating vs Harvesting       Full Show: HERE     Investing Topic: https://brt-show.libsyn.com/category/investing   Tech Topic: HERE   ‘Best Of' Topic: https://brt-show.libsyn.com/category/Best+of+BRT      Thanks for Listening. Please Subscribe to the BRT Podcast.     AZ Tech Roundtable 2.0 with Matt Battaglia The show where Entrepreneurs, Top Executives, Founders, and Investors come to share insights about the future of business.  AZ TRT 2.0 looks at the new trends in business, & how classic industries are evolving.  Common Topics Discussed: Startups, Founders, Funds & Venture Capital, Business, Entrepreneurship, Biotech, Blockchain / Crypto, Executive Comp, Investing, Stocks, Real Estate + Alternative Investments, and more…    AZ TRT Podcast Home Page: http://aztrtshow.com/ ‘Best Of' AZ TRT Podcast: Click Here Podcast on Google: Click Here Podcast on Spotify: Click Here                    More Info: https://www.economicknight.com/azpodcast/ KFNX Info: https://1100kfnx.com/weekend-featured-shows/     Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.  

In September 2023, Dr. Arati Prabhakar, Chief Science and Technology Advisor to the President of the United States, joined Download on Tech host and ITI's President and CEO Jason Oxman for an insightful dialogue on safe and responsible AI. As a key voice on AI in the Biden Administration, Dr. Prabhakar shares with Jason strategic initiatives and partnerships shaping the responsible integration of AI into the U.S. tech landscape and highlights the collaborative efforts between the tech industry and the public sector to forge trustworthy AI systems.

Cannabis Innovation by Ally Biotech w/ Dr. Chuck & Francis - BRT S04 EP36 (199) 9-10-2023                    What We Learned This Week Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products Cannabis is competitive and it's all about the product quality. Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry.       The goal of the company is to adopt the practices of big Pharma and make high grade products.       FDA and DEA are actually working together. The DEA treats cannabis like any other Schedule One dangerous drug, like cocaine or heroin. Yet it does not have the same affects, nor addictive qualities.       Many pain medication's have very serious side effects as well as the potential for problems with overdosing. Cannabis is a good alternative for pain mgmt.       Guests:   Dr. Chuck Johnson, CSO at Ally Biotech  After earning his BA in Chemistry from Northwestern University and PhD in Analytical Chemistry from Virginia Tech, Dr Chuck refined his craft while working The Procter & Gamble Company, Koch Industries, and Danaher, and expanded his scope of knowledge while working and consulting for DuPont, BATF, FBI, Army Corps of Engineers, Chiyoda Engineering, Toyo Engineering, Japan Gas Company, Yamato, Fisher Scientific, VWR Scientific Products, among others. Chuck brings with him experience with FDA regulatory compliance, LEAN (TPS) principles in Product Development and Manufacturing, competitive market analysis, mergers and acquisitions and technical sales. More recently he has provided consultation services and served as the Chief Science and Operations Officer in the Hemp and Cannabis sectors, including industrial farming, extraction, refining, GMP production, nutraceuticals, and FDA compliance.    Francis Baczek, V.P. of Business Development at Ally Biotech  Francis Baczek serves as Vice President of Business Development at Ally Biotech, a provider of leading-edge bioactive delivery solutions for cannabinoids. Baczek brings significant product development experience in the medical cannabis sector. Since 2013, he has been formulating precision-dosed edibles as lead cannabis chef for Uncle Herb's Health Center, a licensed Arizona operator. Baczek is credite      https://allybiotech.com/about-team/   About Ally Biotech:  Headquartered in Payson, Arizona, Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products since 2019. The company recently acquired the Chill Pill line of products. The company's Lipofusion® delivery technology combines nanotechnology and liposomal science to speed product differentiation and innovation. Ally Biotech offers product development services, and manufacturing-ready, water soluble Lipofusion THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. All of the company's products undergo rigorous testing for purity, potency, safety and efficacy at third-party laboratories. For more information, visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com.    About Chill Pill:  The Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry. Formulated using hemp seed oil, Chill Pills are easy to absorb, metabolize, and come in a variety of strengths and strains, with effects ranging from highly responsive to highly relaxed. Chill Pill is owned and operated by Ally Biotech, a company committed to harnessing the power of science to create innovative THC products, such as their patented Lipofusion® technology. For more information, visit ChillPillsAZ.com.     Notes:   Seg 1   Cannabis is competitive and it's all about the product quality. Growing cannabis is a seasonal business.   Ally biotech has been around for two years, circa 2021. Working on a new product called Lipo fusion to be determined one will come out.   Ally purchase a product called chill pill in 2023 and they've tightened up the product with some of their own technology to stabilize the brand. They have three or four products.   Dr. Chuck has a manufacturing and farmer background. SOP of the product is the franchise potential.   Chill pill can be taken and a gummy or sugar edible. THC is 10 g per pill with other variations of 510 and even up to 125 g. Can also take it in liquid form.   They got a nighttime version CBN to stay asleep. Another version CBG daytime to give you energy. Any time product with non-enhanced oil.   There's an ongoing discussion of medicinal use for cannabis, vs recreational. Dr. Chuck believes all cannabis products is medicine.   The goal of the company is to adopt the practices of big Pharma and make high grade products.   Seg 2 They are creating pills, but not smokables. AZDHS or department of health has to monitor every product sold in Arizona.   They have the studies so you can check all the tests and confirm their product is safe.   In reality you can't find tests on prescription drugs, and many drugs are imported from Asia. It's hard to know what the actual quality is.   The chill pill products are made in Arizona using plants that must also be grown in Arizona. There is a strict chain of custody on plant growing as well as all types of test things like examples testing for metals.   The ingredients of THC and CBD actually come from the same plant. When they make their product they buy the extract from other easy growers and use easy labs for testing.   Overall the company has a model that would be easy to copy from the state of Arizona to other states.   Quality of most cannabis products is stagnant per Dr. Chuck. Any cannabis product they're making cannot claim use.   FDA costs are huge to run tests and prove use cases. Very few cannabis companies have the budget to do it. Estimated cost of $15 million to pass the FTA test. Cannabis products are not bad for you.   What most people don't realize is that over-the-counter drugs like Tylenol if you take 2 1/2x the recommended dose recommended dose it can actually be toxic.   Cannabis products you take microdoses, it would take 100 times the recommended doss to be toxic.     Seg 3   FDA and DEA are actually working together. The DEA treats cannabis like any other schedule one dangerous drug, like cocaine or heroin. Yet it does not have the same affects nor addictive qualities.   On schedule 2 are many pain medicines like oxycodone. These medicines are extremely dangerous and can be addictive.   Alcohol though regulated it's not on any drug schedule, it's totally legal and only has age restrictions.   Hundred milligrams per charge 10 per unit. Quick factor female cannabis state to state it's federally illegal when you've committed a crime. No interstate commerce. Cannabis must all be within the state.   It's highly regulated and only legal in about 60% of the states. It is unknown how the DEA will handle cannabis long-term. Arizona has a very viable medical market for cannabis as well as for pain medication.   Cannabis can be used for pain and it is less habit-forming. Medicines like steroids which help a lot of things in the body, also have many negative side effects. Any drug you taking must be careful of the dosage and it needs to be controlled.   Many pain medication's have very serious side effects as well as the potential for problems with overdosing. Per Dr. Chuck you take one chill pill at 5 mg and it will bring down swelling and pain in your body may be failing.     Seg 4   Take too much aspirin you can actually overdose very quickly. This is because aspirin is hard on the liver and can cause metabolism issues. 500 mg plus she took an OxyContin also at 500 mg could wind up having an overdose.   Steroids can do damage to the body but it actually takes a lot of time.   CBD and THC hit different receptions in your body receptors in your body and work well together. CBG actually helps with sleep.   Francis has a very personal story or cannabis treatment helped him with focus. Per Francis also helped relieve tumor size and his cancer treatment a few years ago.   He credits cannabis for a faster recovery. Initially during cancer treatment he was taking Percocet pain pills, also taking nausea drugs which he did not want to. Took Cannabis and it took care of everything.   Francis believes that doctor said prescribe cannabis to get people off opiates.   More information go to life is chill or chill pill a Z. They sell wholesale to dispensaries. No sugar in the product.   Try it for what helps you. The chill drops are the first Lipo products you can put the drops in the water. Go to jars locations to get their product.   Both Dr. Chuck and Francis believe and hope THC will be taken off the schedule one drug listing.       Cannabis Topic: https://brt-show.libsyn.com/category/Cannabis-Hemp-Marijuana   Tech Topic: https://brt-show.libsyn.com/category/Tech   Best of Biotech from AZ Bio & Life Sciences to Jellatech: HERE   Thanks for Listening Please Subscribe to the Podcast   AZ Tech Roundtable 2.0 with Matt Battaglia The show where Entrepreneurs, Top Executives, Founders, and Investors come to share insights about the future of business.  AZ TRT 2.0 looks at the new trends in business, & how classic industries are evolving.  Common Topics Discussed: Startups, Founders, Funds & Venture Capital, Business, Entrepreneurship, Biotech, Blockchain / Crypto, Executive Comp, Investing, Stocks, Real Estate + Alternative Investments, and more…    AZ TRT Podcast Home Page: http://aztrtshow.com/ ‘Best Of' AZ TRT Podcast: Click Here Podcast on Google: Click Here Podcast on Spotify: Click Here                    More Info: https://www.economicknight.com/azpodcast/ KFNX Info: https://1100kfnx.com/weekend-featured-shows/   Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.  

Get ready for an extremely informative episode on the importance of teamwork between hygienists and dentists. What makes this episode truly unique is our honored guest, Dr. Nolan, marking the very first appearance of a dentist on our show! Dr. Nolan brings to light the fundamental role of hygienists as the cornerstone of dental practices, emphasizing the connection between successful practice management and the seamless partnership of dentists and hygienists. You won't want to miss this one! Dr. Nolan attended the University of Illinois where he studied chemistry followed by Midwestern University for his DMD in 2014. His research focus is on the development of novel nanomaterials for use in preventative dentistry. He has published on a wide scope of topics including toxicology, remineralization dynamics, and nanotechnology. He is currently the Chief Science officer for Elementa Oral care, and has worked extensively on the development of plant based nanoparticles for their unique anti caries applications.

In this episode, Dr. Will Cole is joined by AG1's Chief Science and Nutrition Officer, Dr. Ralph Esposito. By showing us the importance of various nutrients for enhanced longevity and optimal health, Dr. Esposito shows us what both conventional MDs and the health world get wrong about nutrition and optimal health. From the most common nutrient deficiencies to be aware of, what we get wrong about recommended daily intakes, what supplement + food labels actually mean, and why nutrient synergy is key to overcoming deficiencies, this episode answers every question you've ever wanted to know about nutrients. Plus, he shows us the benefits of AG1 and why it's so much more than an influencer green drink. For all links mentioned in this episode: www.drwillcole.com/podcastPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:Thank you to AG1 for sponsoring this episode. You can visit DrinkAG1.com/willcole for a free 1 year supply of vitamin D and 5 free travel packs Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After the success of previously unknown biopharma company BioNTech in combatting Covid, Germany is back in the spotlight as “the world's pharmacy.” But what comes next for the sector? And how can international health-sector companies profit? We talk to the world's oldest pharmaceutical company Merck, a serial entrepreneur and a biotech journalist about personal medication, international partnerships and mRNA technology and its potential for fighting cancer. Our guests  Laura Matz is the Chief Science and Technology Officer for Merck, Darmstadt, Germany. An executive vice-president, she's responsible for the corporate innovation teams including the digital office and new digital business models. She has 20 years of experience in semiconductor manufacturing and a decade of experience running semiconductor materials businesses. She has a PhD in analytical chemistry from Washington State University. Maike Becker-Krüger studied International Relations at Lake Forest College in Chicago and at Franklin University in Switzerland. This was followed by an MBA from Quadriga University Berlin. She worked directly for state premier of the regional German state of Hessen before taking responsibility for European policy coordination within the national government. Starting in 2015, she has built up the capital city office and the Corporate and Government Relations Berlin department at Merck. Since 2022, Maike Becker-Krüger has been Head of EU & Germany Corporate Affairs. Oliver Schacht is a corporate finance professional and expert in the molecular diagnostics industry and CEO of OpGen. He has co-founded several start-up companies in biotech, clean tech, IT and education in Europe and the US and has experience in developing and implementing commercial strategies and financing measures (including two IPOs). He also serves as the chairman of the Board of Internal Council of Biotechnology Assocations and the president of the German industry association BIO Deutschland. He studied European Business Administration in Reutlingen and London and holds a PhD from Cambridge University (UK). Dr. Georg Kääb studied biology in Regensburg and Munich and earned his doctorate in neuroimmunology. After freelancing for the Süddeutsche Zeitung newspaper, he became editor-in-chief and co-managing director at the Association of German Biologists. From 2007 to 2021, he headed the communication of the cluster organization BioM (Martinsried), was managing director of the Biotechnology Cluster Bavaria and spokesperson for BioRegions in Germany. Since autumn 2021, he has headed the editorial team of the biotechnology magazine division at media company BIOCOM AG. Send your feedback and comments to andreas.bilfinger@gtai.com.

New Zealand cannot arrest its way out of the gang problem. That's according to a report by the Chief Science Advisory - requested to inform policy for reducing gang harm. It instead calls for improvements in addressing related factors such as family harm, youth offending and drug use. Co-author Tracey McIntosh says legal action over simply being associated with gangs causes collateral damage. "That's largely with children and with women. And it means you have much more distrust in a community and those young people who you actually don't want to enter into a pathway of gangs actually feel that they have no other opportunity." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Moderator: Tom Reuner, Executive Research Leader, HFS Panelists: Angela Johnson, Partner - Head of Capital Formation, Fifth Wall Armen R. Kherlopian, Ph.D., Chief Science and Innovation Officer, Covenant Venture Capital Rajesh Rajappan, Senior Vice President - Global Markets, Hitachi Vantara Nitin Rakesh, CEO & MD, Mphasis Ted Shelton, Expert Partner, Bain & Company Session Description: HFS has outlined the vision, but how do we operationalize the autonomous enterprise? Many organizations still struggle to scale their low-level automation projects. Is it realistic to expect machines will make decisions without human interaction? How should we adapt the innovation agenda to finally get data and workflows out of silos? We'll hear from leaders driving the innovation agenda discuss and debate these questions: How do you design the innovation agenda to enable the autonomous enterprise? How do we need to think about the operating model? What will the most important change agents be: next-gen AI and industry cloud or culture and governance? How do you safeguard the necessary skills amid the war for talent?

We found our previous episode with Frank G. Howard, the CEO of GeneIQ, so interesting and important that we wanted to dive even deeper into pharmacogenomics with Dr Tariq Adwan, the Chief Science officer of GeneIQ. The short definition of pharmacogenomics is the science of determining the genetic variability that influences physiological response. This means that instead of a whole lot of trial and error with medications, people can get the medication that is genetically most likely to be accepted by the body. This means less side effects, and less medications to treat those side effects, along with many other benefits. Learn more about this new science, the benefits and what it takes to get this program started for someone truly in need. Knowing what medications are right for each person can mitigate the need to throw many medications, on average 15 medications for seniors, to treat their health concerns.

Welcome to Episode 1 of our Podcast series with AG. as we explore the philosophy of Foundational Nutrition (FN) and its profound impact on overall health. We are honored to have Dr. Ralph Esposito, Chief Science & Nutrition Officer at AG, as our first guest. Dr. Esposito shares his deep understanding of the problems with the modern diet and healthcare approach, and how FN provides a much-needed solution. We begin by examining the shortcomings of the modern diet, with its prevalence of processed foods, excessive carbohydrates, and sugar-laden choices, often lacking in diversity. Dr. Esposito emphasizes the importance of whole foods, yet highlights the challenges of obtaining adequate micronutrients daily.Delving into the modern approach to healthcare, Dr. Esposito sheds light on the reductionist mindset that fails to address the root cause problems within the body. He emphasizes the interconnectedness of various bodily systems such as the Brain, Gut, Immune, Metabolic, Cardiovascular, and Hormonal systems, emphasizing the need for a holistic approach. Our guest addresses the complexity of the supplement aisle and challenges the notion that a trip to a health store can provide a personalized solution. He explores the pitfalls of most supplements on the market and introduces FN as the foundational supplement that everyone needs before delving into specialized options. Finally, we discuss how FN fits into the broader concept of a healthy life, highlighting the importance of Foundational Health. Dr. Esposito touches upon the pillars of movement, sleep, nutrition, sunlight, social relations, and mindset, showcasing the role FN plays in supporting a well-rounded and healthy lifestyle.Don't miss this enlightening conversation with Dr. Ralph Esposito, Chief Science & Nutrition Officer at AG, as we explore the transformative power of Foundational Nutrition and its vital role  for a thriving life. For further information on AG - athleticgreens.com/trx For further information on TRX - https://www.trxtraining.com/

Whether as a patient, a caregiver, a neighbour or a friend, chances are, one day, we will all be touched by Alzheimer's or dementia. This disease steals our memories and cruelly robs us of our loved ones, often when we need them the most. But, there is hope and momentum in the world of Alzheimer's research. In fact, a new theory suggests that Alzheimer's could even be an autoimmune disease. In this episode of Your Complex Brain, we speak with Dr. Donald Weaver and Dr. Saskia Sivananthan. We'll also hear from Lindsay Bongard-Batori, who lost her mother Barbara to Alzheimer's. Featuring: Dr. Donald Weaver – Neurologist, medicinal chemist & Senior Scientist with the Krembil Brain Institute at UHN. Dr. Weaver is an internationally recognized research leader in university-based drug design and discovery for neurological disorders. Dr. Saskia Sivananthan – Neuroscientist & Chief Science and Knowledge Translation Officer at the Alzheimer Society of Canada, overseeing the Alzheimer Society Research Program, a dementia research priority setting leader. Lindsay Bongard-Batori - Lost her beloved mother Barbara to Alzheimer's in 2020, and hopes her story will help others caring for their loved ones.Additional resources: Dr. Donald Weaver's lab websiteUHN – Dementia & Neurodegenerative DisordersAlzheimer Society of Canada (for information on latest research awards, patient stories, help for caregivers, provincial chapters)Alzheimer Society of Canada HotlineLandmark Study: Navigating the Path Forward for Dementia in Canada(VIDEO) A New Theory of Alzheimer's (featuring Dr. Weaver)(VIDEO) Living with Dementia: A Caregiver's Perspective(VIDEO) Risk Factors for Alzheimer's and Dementia(PODCAST) What is it Going to Take to Cure Alzheimer's (featuring Dr. Weaver + Patty Kim)The Krembil Brain Institute, part of University Health Network, in Toronto, is home to one of the world's largest and most comprehensive teams of physicians and scientists uniquely working hand-in-hand to prevent and confront problems of the brain and spine, such as Parkinson's, Alzheimer's, epilepsy, stroke, spinal cord injury, chronic pain, brain cancer or concussion, in their lifetime. Through state-of-the-art patient care and advanced research, we are working relentlessly toward finding new treatments and cures.Do you want to know more about the Krembil Brain Institute at UHN? Visit us at: uhn.ca/krembilTo get in touch, email us at krembil@uhnresearch.ca or message us on social media:Instagram - @krembilresearchTwitter - @KBI_UHNFacebook - https://www.facebook.com/KrembilBrainInstituteThanks for listening!

Scott Jones talks about a wide range of topics In his visit, from his role as Chief Science Officer to his latest interests in music to his family's version of his new job title.

Scott Jones, Chief Scientific Officer at BioBridge Global, talks about his job in a snippet of his upcoming appearance on Hearts Afire.

Today on Vermont Viewpoint, Kevin Ellis hosts! During the first half of the show, we'll get a COVID update with the Chief Science and Global Health Reporter from the New York Times. Kicking off the second half of the show, he'll speak with Bob Ney about the State of the Union. After that, he'll talk with Seven Days about the Politics of Police in Burlington. And he'll finish off the show with open phones.

In this special podcast we will focus on the changes in recommendations for CV Risk Reduction published in the 2023 American Diabetes Association's Standards of Care. The report is available at:   https://professional.diabetes.org/content-page/practice-guidelines-resources    Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Robert A. Gabbay, MD, PhD, Chief Science and Medical Officer, American Diabetes Association

Saskia Sivananthan, PhD, is Chief Science and Knowledge Translation Officer at the Alzheimer Society of Canada, where she oversees the Alzheimer Society Research Program.  She is a neuroscientist and health data scientist focusing on dementia care. In 2020, the Federal Minister of Health (Canada) appointed her to the Ministerial Advisory Board on Dementia. She also served as a senior strategy and policy advisor on the global dementia strategy for the World Health Organization (WHO) and co-drafted their Global Action Plan on the Public Health Response to Dementia. Ms. Sivananthan will discuss highlights from Canada's National Dementia Strategy and Navigating the Path Forward for Dementia in Canada: The Landmark Study Report #1, which addresses the current direction of dementia in Canada and its impact on people living with dementia and their care partners. Original air date: January 11, 2023 ____________________________________________ McGill Cares is supported by the Amelia Saputo Community Outreach for Dementia Care. McGill Cares is an initiative of the McGill Dementia Education Program, which is funded by private donations. To contribute or for more information about our program, please visit http://www.mcgill.ca/dementia. This page also contains a link to trusted resources specific to dementia. If you have any topics or questions that you would like us to address during our weekly webcasts, please email us at dementia@mcgill.ca.

Barcelona has emerged as one of the EU's top startup hubs, and we wanted to learn about the factors that set the city up for success in this space, as well as how European and American cities can contribute to innovations in the science and technology spheres. We sat down with Alexis Roig, the CEO and Barcelona's Chief Science and Technology Envoy, to learn more about his role in connecting cities, foreign affairs, and science diplomacy. The Europe Desk is a podcast from the BMW Center for German and European Studies at Georgetown University in Washington, DC. It brings together leading experts working on the most pertinent issues facing Europe and transatlantic relations today. Music by Sam Kyzivat and Breakmaster Cylinder Design by Sarah Diebboll. Leadership: Flora Adamian, Jakob Winkler. Production by Flora Adamian and Drew Fenner. Communications by Shelby Emami, Ryan Conner, Mason Kane, Sophie al-Mutawaly, and Flora Adamian. https://cges.georgetown.edu/podcast   Twitter and Instagram: @theeuropedesk If you need more information about the Center's events, or have any questions or feedback, please email: theeuropedesk@georgetown.edu.

December 12, 2022: A special episode today. Interviews with cutting edge innovation leaders direct from the floor of HLTH ‘22:Taha Kass Hout, Vice President Machine Learning and CMIO for AWsNeil Sharma, Executive Vice President at Sword HealthErich Huang, Chief Science & Innovation Officer and Tarun Galagali, Product Marketing & Product Strategy for OnduoCharlie Lougheed, CEo and Co-Founder of AxuallSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week Health

Are you already tapping into digital technologies to transform the way you compete, collaborate, and connect? At the launch of Siemens Xcelerator, an open digital business platform, Siemens Digital Industries CEO Cedrik Neike welcomed three guests whose companies have made big strides in their digital transformations: Laura Matz, Chief Science and Technology Officer at Merck, spoke about how digitalization is speeding up the development of therapies. Patrick Verwer, CEO of Govia Thameslink Railway, or GTR, presented how digitalization is helping to deal with growing passenger volumes on legacy infrastructure. And Trond Skjellerud, CEO of Elvia, talked about managing the grid in the age of electric mobility. Host Alex Chavez guides you through this episode. Siemens Xcelerator: www.siemens.com/xcelerator

Dr. Jeremy Babendure, Executive Director at the SciTech Institute, talks about his first vision of creating opportunities for students to get involved in STEM through his CSO's initiative. A vision that has made its way all the way to The White House because of students' work and dedication to STEM. Learn all about this initiative in today's episode.

In this episode of Curbside Consults, we examine the latest standards of medical care published by the American Diabetes Association (ADA). We are joined by Bob Gabbay, who is Chief Science and Medical Officer at the American Diabetes Association, an Associate Professor of Medicine at Harvard Medical School, and one of the authors of the ADA's new 2022 Standards of Medical Care in Diabetes document.

NEJM Group In this episode of Curbside Consults, we examine the latest standards of medical care published by the American Diabetes Association (ADA). We are joined by Bob Gabbay, who is Chief Science and Medical Officer at the American Diabetes Association, an Associate Professor of Medicine at Harvard Medical School, and one of the authors of the ADA’s new 2022 Standards of Medical Care in Diabetes document. https://www.listennotes.com/e/fdce9586151f456da485dff078e7410c/

Wednesday Sept 7th - James Webb Telescope - Chief Science Communications Officer Bethany Downer by VOCM

In this episode, Jess interviews our CSO Natalie and Founder Lynndsey about Natalie's Role as our Chief Science officer, and the ladies get into a discussion all about evidence-based training design.    They cover periodization, progression, rest periods, deloads, exercise selection, and how to adjust these things for a beginner or someone with a chronic disease or condition.     

In this episode, Françoise von Trapp interviews Laura Matz, CEO of Athinia™ and Chief Science and Technology Officer of Merck KGaA, Darmstadt, Germany, about the growing need for data collaboration between materials suppliers and semiconductor device manufacturers, and the solution she helped create. Over the past 10 years, more new materials have been introduced into semiconductor manufacturing at each device node. At the same time, processes continue to tighten. This is increasing sensitivities to materials variations. Because of this, materials companies have to publicly communicate on excursions in the materials supply chain. Until now.  Matz explains how a secure data ecosystem platform can use Big Data and AI to solve these issues. She provides details on how this platform addresses both IP security and cybersecurity. The platform she describes, Athinia™, was launched in December 2021. This secure data collaboration platform allows semiconductor device manufacturers and materials suppliers to share, aggregate, and analyze data to unlock efficiencies and time to market while improving quality, supply chain, and sustainability.   Six months in, Matz has some exciting news to share about a collaboration with Micron. She also talks about her role in conceptualizing this platform and bringing it to life.  Athinia - Data for Pioneers Building a secure data ecosystem to solve some of the toughest semiconductor industry problems.

In our August Broadcast, we are delighted to be joined by Dr Helen Ferrier, Chief Science and Regulatory Affairs Adviser at NFU and Trustee Director of NIAB Board. Helen leads the National Farmers' Union's policy and advocacy work on agricultural and horticultural science and research, biotechnology, data, and food safety, on behalf of the NFU's 55,000 members in England and Wales. Based at NFU HQ in Warwickshire, she leads a policy team covering plant health and crop protection, farm safety, skills and training, transport, labour and employment. Helen is a non-executive Director of the NIAB Board, chair of the Crop Science Centre Alliance Board and is a member of many other groups and panels in the agrifood and research community. Before joining the NFU in 2004, Helen was a research scientist at Imperial College London, working on probabilistic modelling of dietary exposure to pesticides. She has an academic background in environment and human health, epidemiology and environmental science.

Excited to have Chief Science officer, Kevin Longoria, from Biostrap, a biometric wearable that measures/monitors everything from arterial health, heart rate, sleep, heart rate variability (HRV), movement, and much more. Biostrap is on a mission to provide the world's most advanced, science-based platform to improve global health.To get 10% off any wearable, head over to www.biostrap.com and enter the code JOELEVAN at checkout.There's lots of fitness trackers out there such as FitBit, Whoop, etc, but Biostrap is my favorite based on the quality control of the data and the way they gather it. In this episode we dive into how Biostrap is able to predict possible sickness or injury, improve sleep, the fascinating things they're doing with heart health, and the studies they've conducted on fitness products and supplements.If you're looking for holistic health coaching and getting to the root cause of your issue, or you want to lose weight permanently through a holistic method that focuses on mindset, nutrition, detox, and habit mastery, then  DM me “I'M READY”@joelevancoaching or email me info@joelevancoaching.com [www.joelevancoaching.com]Timeline3:00 - What makes Biostrap unique and different from other wearables5:47 - Are we still a long way from collecting valuable data?8:00 - How Biostrap determines how you might be at risk of injury or other sicknesses12:35 - What Biostrap is used for mostly by users16:37 - How Biostrap helps with heart health19:50 - How Biostrap predicted the C-virus in individuals based on arterial elasticity21:17 - How athletes are using the Biostrap device22:45 - Biostrap Labs: how you can test the efficacy of your product with Biostrap26:57 - Efficacy of soft shell HBOT chambers 27:11 - How saunas improved sleep drastically29:58 - How the Neufi helped with HRV and less pain36:50 - What is Biostrap SleepLab and how they can tell you your circadian rhythm Other Resources/LinksBiostrap's website - use code JOELEVAN for 10% off at checkout

In an extended and extensive interview, Dr. Perakslis drew on his experience in industry, regulatory agencies, and academia as well as his book co-authored with Martin Stanley, Digital Health: Understanding the Benefit-Risk Patient-Provider Framework, to address the following questions: How do we tackle the challenges of the unintended (and undesired) effects of healthcare inventions and innovations for patients? How do the perspectives of leaders of inventors/innovators/developers, regulators, and researchers in healthcare vary from one another in evaluating the importance of the work they oversee? What are the attributes of effective leaders of healthcare organizations that are more or less generic and which are more specific to organizations engaged in drug and device development, in regulating healthcare innovations, and in evaluating the effectiveness and safety of new products and services? Where do you see the newest frontiers for breakthrough developments stemming from digital health? Immediately prior to joining the Duke Clinical Research Institute, Dr. Perakslis was senior vice president and head of the Research & Development Institute of Takeda Pharmaceuticals and that company's work in oncology, rare diseases, neuroscience, and other fields.  Previously, he also held positions at: Harvard Medical School and Boston Children's Hospital; U.S. Food and Drug Administration; senior vice president at Johnson & Johnson's Pharmaceutical R&D Information Technology;  and ArQule, a drug development company acquired by Merck. Innovators is a podcast production of Harris Search Associates.  *The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*

Demand for a local seaweed-based biostimulants jumped 200 percent this autumn compared to the same time last year, partly driven by price hikes for synthetic fertilisers, as the war in Ukraine affects global supplies. AgriSea has been making biostimulant products for 25 years, and says demand is also growing as farmers become more conscious of where farm inputs come from. AgriSea collects seaweed from remote shores of coastal New Zealand and brews the harvest into a nutrient-rich concentrate at a factory in Paeroa. The company is also developing a seaweed farm in the Hauraki Gulf. The final product is a bio-stimulant, which enables farms and orchards to improve outcomes for soil, pasture, plant and animal health. Seaweed is a burgeoning sector in New Zealand, and globally, the seaweed sector is estimated to be worth more than $20 billion. Kathryn speaks to the chief executive of AgriSea, Clare Bradley about the industry. She also speaks with Fonterra's Chief Science and Technology Officer, Jeremy Hill, initiatives Fonterra is exploring to reduce greenhouse gases, including trialling a supplement for cattle containing Asparagopsis seaweed.

Sea levels are rising twice as fast as thought in New Zealand, significantly reducing the amount of time authorities have to respond. But there's a new weapon in regional and unitary councils' armoury to combat the pressures on communities of climate change, as well as for managing land, air, and water resources. The sector's inaugural Chief Science Advisor is Dr Chris Daughney. Te Uru Kahika created this role in recognition of increased pressure on local and regional government from sea level rise, among other pressing environmental issues. Kathryn speaks with Dr Daughney, who is also Chief Science advisor at NIWA.

Jacinto is Chief Science and Innovation Officer and most importantly founder and brain behind the technology of Peafowl Plasmonics as well as Professor at Uppsala University in Sweden. We learn about his journey from research to startup and he gives us an understanding of plasmonics, the physics of solar cells and the new opportunities his research brings. With a platform technology like his, Jacinto shines light on how he thinks about finding the best use case for your technology.We learn about the specialties of the Swedish tech transfer system, how they think in a circular manner but also about the moral responsibility that Jacinto thinks lies on scientists to make use of their technology. And most importantly, we get to know Jacinto as someone who is a master at separating his ego from the success of his company. We hear the story of how he found an external co-founder and CEO and built a trustful relationship with him to make Peafowl Plasmonics succeed.

SHOW NOTES (Bonus Pre-Season Episode) Evidence indicates the Stegosaurus did not swish its spiked tail back and forth like a Medieval weapon, but rather used it for locomotion and communication, and when need be for defense. Morrison Natural History Museum Director Matthew Mossbrucker provides the non-gory details in his interview with Michelle Howell. Dinosaur Ridge volunteer Jim Watson surmises how the Stego may have sounded — his interpretation is unlike any Hollywood version you've heard. Finally Dr. Nicole Peavy of the Colorado Department of Transportation (CDOT) talks about the work of Mitigation Paleontology, and what happens with fossils found on road construction sites. The Stegosaurus used its tail like a third leg! It helped move the animal, and also could be used to communicate with other Stegosaurus, and defend the animal from predators. Matthew Mossbrucker discusses the anatomy of the tail, including the lump of bone called the fourth trochanter, that served as a muscle attachment knob for the caudofemoralis, a muscle found in nearly all animals with tails. In 2009, Mossbrucker and Dr. Robert Bakker studied the tail and published “The Symposium on Stegosauria” In our conversation, Mossbrucker mentions Quarry 13 in Como Bluff, Wyoming which is referenced in this thorough wikipedia post if you would like more context. Dr. Nicole Peavey mentioned paleobotany finds at Denver International Airport, more can be seen on the Denver Museum of Nature and Science website here. Peavy also referenced the Castle Rock Rainforest uncovered during a highway project. At the time the Dr. Kirk Johnson (Smithsonian's National Museum of Natural History Director) was with the Denver Museum of Nature and Science, which now holds 10,000 specimens from this site. He wrote an article about the finds that was published in 2003. Peavy also referenced Ian Miller, now National Geographic Society's Chief Science and Innovation Officer, who also worked at the Denver Museum of Nature & Science. Miller has led science research projects on major field expeditions across the western U.S. and Madagascar. If you've never heard how the term “Thagomizer” came about, you must first treat yourself to a popular newspaper comic strip from the 1980s called “The Far Side.” Author Gary Larson in a 1982 comic drew a group of cavemen attending a lecture in which the speaker points to the tail tip of a Stegosaurus. The caption explains the spikes are called Thagomizers "after the late Thag Simmons.” Denver Museum of Nature and Science paleontologist Kenneth Carpenter jokingly used the term at the Society of Vertebrate Paleontology Annual Meeting more than a decade later, and it caught on. Fossil Butte National Monument in Wyoming is the scene of world-renowned fossil finds including 27 types of fish. And as you will learn, in some cases the data is more important than the fossils themselves.   Our theme music was composed by Hansdale Hsu. Additional music titled “Call to Adventure” provided by Kevin MacLeod of icompetech.com via http://creativecommons.org/licenses/by/4.0/ Thank you for listening!  Stay tuned for Season One coming this spring 2022!  

Mike Hudy the Chief Science Officer for screening tool Modern Hire is here to talk about AI in recruiting as well as their new AIC (automated interview creator) feature. New Rec Tech!

Robert Popovian, PharmD, discusses what the profession of pharmacy can learn from the recent pandemic.

Health care should not be one size fits all.   That's according to Dr. Erich Huang, Onduo's Chief Science and Innovation Officer. Huang has a long career in academic medicine at Duke University, and now spearheads clinical evidence generating programs and research at the virtual care company, which is based in Newton, Mass.   Huang, who is a Ph.D. and a medical doctor, notes that in today's healthcare environment, there is little room for personalization. But he and his team at Onduo are working hard to change that.   “We need to be part of people's lives to get signals that are health relevant and then help navigate them to better health,” he says.   He discusses how health care providers need to look at an individual's activities, or a series of tests, to find better ways to personalize their care. Taking these signals from the course of an individual's life and using them to tailor care over time is the future, states Huang.   Press play to hear more of Dr. Huang's expertise about how employers are improving and further personalizing benefits and what the future holds.

We look into our brains to answer if True Love is real? How to find a mate? Keep one? Do opposites really attract? Our guest is Dr. Helen Fisher, anthropologist, an expert on the neuroscience of love, and the Chief Science advisor of Match.com. She's seen it all lately- from the eternal qualities of mate selection to changing trends in love during covid, to why the next generation of families might be more stable, and how, according to our brain, to make love last. Dr. Fisher gets personal and shares it all with us.

If you're looking for real conversations with real technology leaders about practical solutions, you've come to the right place. In this introductory episode, the 3 hosts from ChaosSearch join us: - Thomas Hazel, Founder, and Chief Science and Technology Officer - Dave Armlin, VP Customer Success and Field CTO - Courtney Pallotta,VP Marketing They're here to kick off the informal, unfiltered, fun conversations to be had on the show. Join us as we discuss: The biggest challenges in the industry today Who the podcast is for The types of conversations featured on the show   To make sure you never miss an episode of Data Legends: Stories from the IT Trenches podcast, subscribe on Apple Podcasts, Spotify, and the website. Listening on a desktop & can't see the links? Just search for Data Legends: Stories from the IT Trenches in your favorite podcast player.

Tuesday Jan 25th - Webb Space Telescope Chief Science Communications Officer Bethany Downer by VOCM

Enabling connected, whole-person care starts with the health IT team. In this conversation with Erich Huang, MD, Ph.D., Chief Science and Innovation Officer at Onduo, you'll hear his perspective on how health systems can empower their IT teams to think creatively about their tech stack and how to leverage data to drive innovation in interoperability and care delivery; with real-world examples of how Duke Health applied data to improve predictive modeling to identify patients who need different approaches to care delivery and his thoughts on the future of data in healthcare at an Alphabet company.This episode is sponsored by Onduo.

In this show Joan speaks with Ronnie Gonzalez of IAM Mechanics Local 701 Union. Dr. Dale Bredesen, Co-founder and Chief Science officer of Cognitive Health Centers. Mark Karlin Of Buzzflash.com. And Tim Hogan and Issac Wright of Forward solution strategy group.

Dr. Eric Perakslis, PhD is the Chief Science and Digital Officer at the Duke Clinical Research Institute.  In this incisive discussion, Eric exposes the curious nature of healthcare data. He proposes treating data like a digital specimen: one that requires clear consent and protection against misuse. Expanding our view beyond the doctor's office, Eric shows why adverse effects from data misuse can be much harder to cure than a rash. As well as our innate human tendency to focus on technology's potential while overlooking patient vulnerabilities. While discussing current data protections, Eric lays the foundation for a shift from privacy toward non-discrimination. Along the way, Kimberly and Eric discuss the many ways anonymous data can compromise patient privacy and the research it underpins. In doing so, a critical loophole in existing institutional review boards (IRB) and regulatory safeguards is exposed. An avid data advocate, Eric adroitly argues that proper patient and data protection will accelerate innovation and life-saving research. Finally, Eric makes a case for doing the hard things first and why the greatest research opportunities are rooted in equity.  A transcript of this episode can be found here. Our next episode features Yonah Welker. They are a ‘tech explorer' and leading voice regarding the need for diversity and zero exclusion in AI as well as the role of social AI. Subscribe now so you don't miss it.  

After 32 years as a university academic in chemistry in Australia and the US. Dr Roy Tasker joined Planet Ark in July 2018 as Chief Science advisor. With a passion of communicating science through visualization, Roy uses his experiences to help people to understand important scientific issues relevant to climate change and promote meaningful behavior change.

Jayshree Seth is a Corporate Scientist and Chief Science Advocate at 3M. She has Bachelor's and Master's Degrees and a PhD, all in Chemical Engineering. She holds 72 patents! She was recently featured in the documentary "Not the Science Type", a documentary that premiered during the Tribeca Film Festival this summer. She is the author of "The Heart of Science: Engineering Footprints, Fingerprints, and Imprints".Episode NotesJayshree Seth didn't think she wanted to be an engineer or scientist. She had a strong interest in humanities subjects and grew up knowing that she wanted to help people and make a difference in the world. Her parents strongly encouraged her to go into engineering and she eventually saw that engineers and scientists DO help people and are change makers in the world - and she is passionate about sharing that message and encouraging women and underrepresented minorities to pursue STEM careers knowing a humanities mindset is huge component of success in STEM.We talk about the documentary "Not the Science Type", her public facing role as a Chief Science Advocate (sounds like the coolest job ever), her book "The Heart of Science: Engineering Footprints, Fingerprints, and Imprints" which is a great collection of advice and articles about STEM and whose proceeds go to fund scholarships for a woman of color. We talk about the need to change narratives and archetypes around STEM careers, motherhood, communication skills, and so much more.Music used in the podcast: Higher Up, Silverman Sound StudioAcronyms, Definitions, and Fact CheckNot the Science Type: https://www.youtube.com/watch?v=AgHIoyZjMCI. "Not the Science Type" is an incredible four - part documentary series that will quickly disabuse you of that notion. In the series you will meet four amazing female scientists who are ushering in a new future, as they address critical global and local challenges. These brilliant women have faced sexism, racism and ageism in their professional journeys and in response, they have shattered stereotypes with each new innovation, patent and award. The Heart of Science: Engineering Footprints, Fingerprints, & Imprints - https://www.amazon.com/Heart-Science-Engineering-Footprints-Fingerprints/dp/0578785129/ref=tmm_pap_swatch_0?_encoding=UTF8&qid=1608578292&sr=8-1The Heart of Science explores big ideas through a collection of insights, reflections and tips from Jayshree Seth's successful corporate career in research and development that spans over 25 years and includes 72 patents, as well as national and international accolades. All proceeds from the sale of the book will support the Jayshree Seth Scholarship for Women of Color in STEM. (https://alltogether.swe.org/2020/12/the-heart-of-science-jayshree-seth/)3M State of Science Index Survey - For the fourth year, 3M is sharing unique insights from our original research project, the State of Science Index. The State of Science Index is a third-party, independent research study commissioned by 3M that tracks and explores global attitudes toward science, taking the pulse on how people think and feel about the field and its impact on the world around us. Last year, we released two waves of data at once: one which was fielded a few months before the pandemic hit in August-October 2019 (called 2020 Pre-Pandemic Survey), and a second full data set from a pulse survey conducted during the pandemic in July-August 2020 (called 2020 Pandemic Pulse). About six months later (February-March 2021) and one year into the epidemic, we fielded the 2021 survey to help us understand the longer-term impact that the pandemic and other major economic and social justice milestones have had on global views on science and top scientific issues. (https://www.3m.com/3M/en_US/state-of-science-index-survey/about-the-survey/)

The Jeffs talk with Dr. Bill McCoy, Chief Science & Technology Officer at Phigenics. Check it out as they dig into:          • How & why innovation starts with defining a problem to solve          • Recruiting, selecting & retaining quality, innovative talent          • New technologies & the future of innovation at PhigenicsPhigenics LLCFollow Us on Facebook, Instagram, or TwitterGet in touch InnovationJunkie.com 

“We wanted to offer a product that makes the user say, ‘I can't believe this isn't plastic!'”Tim Busby (9:49-10:01) When John Oakley and Tim Busby came together to create Matter™, they were dead set on creating a product that can truly be a one-to-one alternative to single use plastics. Matter™ products are biodegradable, free from heavy metals, FDA approved and making it easy for you to improve your sustainability efforts.   When you visit NatureStar's Matter™ website, you might be confused when you see “allergen free”, “gluten free”, “non-GMO”. Reading those disclosures are typically only seen on food labels! Instead, the Matter product line includes snack bags, sandwich bags, storage bags, kitchen bags, food wrap, plates, bowls, cutlery, straws and much more. As John Oakley and Tim Busby like to say, the Matter line of products are “from nature, back to nature” and developed from a polymer that literally breaks down back to nature, unlike plastic.   “Things in our life are starting to matter more and more because we have to take care of Mother Earth.” John Oakley (10:49-10:53)   Polymer? Back to nature? What does that exactly mean? Most disposable products, like plates, cutlery, cups, plastic bags, and so on, are derived from oil and end up in a landfill where the product won't break down for hundreds or thousands of years. In a matter (no pun intended) of months, the Matter™ products will compost and disappear into soil because they're made from all natural, renewable and sustainable fibers. This creates something called biomass, which is like an enhancer for soil and makes a bit of water in the process.    Through composting, microorganisms will consume the material and create biomass, which is like an enhancer for soil and makes a bit of water in the process and goes through photosynthesis. The Matter products give back to nature and can be used over again through this sustainable process, unlike plastics which last hundreds and thousands of years.   Think plates and knives made from biodegradable plant materials can't hold up a good, hearty meal? Think again! Even Lori Taylor herself has tested the Matter™ plates, serving her family steaks without worrying if the steak knives would cut through the disposable dish. Even if Matter™ products end up in a traditional landfill or dump, they will still break down in a much shorter time period when they come into contact with microbes since the products are made of starch. Some of the products don't even take months to break down, they take a few weeks!    This product is huge for the US who is behind in terms of composting or sustainability efforts to other countries like the UK. Retailers like Target have picked up on the great opportunity Matter™ products offer consumers and, not to brag, but the company was allotted 20 shelf slots at Target stores from the getgo which is almost unheard of! Even their straws have rave reviews compared to paper ones, which unravel, dissolve, and are either too flexible or not flexible enough.   “We've developed a straw, and it's not a plastic straw or a paper straw, it doesn't unravel, it doesn't dissolve, it's flexible… we've tried to replicate what people are used to in their everyday lives without causing a problem for Mother Earth.” John Oakley (18:57-19:15)   Not only are you giving back to Mother Earth and making our planet long-lasting for our future generations, you're also giving back to veterans with every Matter™ purchase you make. The company is partnered with Folds of Honor, a non-profit organization that provides scholarships to spouses and children of disabled and deceased American veterans, and gives a portion of every purchase to the charity.    How to get involved Join The Produce Moms Group on Facebook and continue the discussion every week!  Reach out to us - we'd love to hear more about where you are in life and business! Find out more here.    If you liked this episode, be sure to subscribe and leave a quick review on iTunes. It would mean the world to hear your feedback and we'd love for you to help us spread the word!

I'm excited to announce the debut of my new podcast, Politex—an insider's perspective of what's happening at your Texas Capitol in real time. Each week, we'll be discussing public policy, a lot of politics, and as a proud San Antonian I can promise you we won't forget about arts and culture. This week, I'm joined by Dr. Michael Webber, the go-to energy resources expert at the University of Texas at Austin and the Chief Science and Technology Officer at ENGIE. Our focus is a topic that's on the mind of many Texans right now: How did our state's energy system fail so badly in the response to last month's winter storm? Like, subscribe, and reach out in the comments to let me know what you think of the first episode!

Switching New Zealand's required method of Covid-19 testing could be on the horizon as the roll-out of voluntary saliva tests widens.Auckland Airport workers are now being offered saliva testing in a bid to add another layer of protection.It comes after the Government last month rolled out the additional testing method for border workers in quarantine facilities.While the Ministry of Health say at this stage there is still no indication that saliva PCR testing could replace the mandatory nasopharyngeal testing, health experts say it's only a matter of time.Otago University epidemiologist Professor Michael Baker said once everyone was convinced the performance of saliva testing was adequate it could certainly replace nasal swab testing."It means we could contemplate the idea of having daily tests as a way of increasing the speed of outbreak protection," Baker said.Baker said it was good New Zealand had multiple laboratories testing out these technologies as the benefits were huge."Saliva testing is a lot less invasive for people ... potentially switching to saliva testing, especially for workforce who are already feeling more vulnerable, could make the job that much easier."Mary-Liz Tuck, Auckland Airport general manager of corporate services, said it made asymptomatic testing simple and comfortable for airport and border workers, while providing the highest standard of protection for the community."We want to see as many protective layers as possible for our people and our community," Tuck said.The airport teamed up with New Zealand business Rako Science that established the Covid-19 surveillance testing in New Zealand using the Shield saliva test developed at the University of Illinois.A collection site in Auckland Airport's international terminal had now been set up to provide the saliva testing and was set to run for three months while scientists measured the effectiveness.Airport staff taking part in the saliva tests were doing so on a voluntary basis, along with the mandatory nasal-swab testing required by the Government's border policies.A Ministry of Health spokeswoman said PCR nasopharyngeal swabbing method was still considered the gold standard for Covid testing as it detects the virus the most effectively."This swab type will obtain the optimal specimen and is the preferred collection method for both symptomatic and asymptomatic testing due to its higher sensitivity in detecting the virus."She said voluntary saliva testing also recommenced this week at the Auckland quarantine facility and at the managed isolation and quarantine facility in Christchurch.Rako Science is using the RT-qPCR saliva-testing protocol developed by University of Illinois which has conducted 1.3 million on-campus tests.Rako Science's Chief Science officer, Dr Stephen Grice, said Rako's science committee had briefed the Ministry of Health in December last year that it had successfully validated and accredited the saliva test for New Zealand.He said they recently provided the ministry with additional data which confirmed the test was as accurate as tests using nasal swabs."Rako Science has the processing capacity for 10,000 tests per day and the sample collection system does not depend on medical professionals to administer the test."Saliva testing for Covid-19 had been accredited for use in New Zealand by International Accreditation New Zealand (IANZ).Separately, Air New Zealand staff were working with the Institute of Environmental Science and Research (ESR) to work out the effectiveness of saliva tests detecting Covid-19.The Rako Science saliva deployment had no connection to trials being run by ESR.Last month, Covid-19 Response Minister Chris Hipkins said Covid-19 the role and effectiveness of saliva testing was still evolving."The Ministry of Health will report back with its findings about the testing in early March," he said at the time. 

In this episode Dr. Jayshree Seth, Corporate Scientist and Chief Science Advocate at 3M talks about the role of science in our lives and the inspiration behind her new book, "The Heart of Science", innovation and how everyone can innovate, and the importance of diversity in STEM. Resources: 3M State of Science Index: https://www.3m.com/3M/en_US/state-of-science-index-survey/ --- Support this podcast: https://anchor.fm/shobhana-viswanathan/support

Today’s podcast features Kelly Hensel, IFT’s senior digital editor, and John Ruff, IFT’s Chief Science and Technology Officer. We’ll be discussing a few of the major trends that both Food Technology Magazine’s editorial team as well as IFT’s Science, Policy, and Innovation team expect to play a major role in 2021. Tags: IFTNEXT, podcast, food … Continue reading Episode 26: Food Industry Trend Predictions for 2021 →

Adrian Percy talks with Jason Wargent, Chief Science officer at Biolumic about photobiology and UV treatments for seeds and seedlings. @AgTech360 agtech360@gmail.com go.ncsu.edu/CERSA southernipm.org

SEATTLE SPIRIT: The first presidential debate of the season is here. Maia and Todd went through the sex Ed curricula. Reject R-90 // A nurse in a hospital talks about medical malpractice getting people murdered. Chief Science officer for Pfizer says “Second Wave” faked on false positive COVID tests. ‘pandemic is over’ // Bloomberg has to tell us? Jay Inslee has a real hacking problem and even more of your data and money is at risk See omnystudio.com/listener for privacy information.

This episode features a round table conversation with Ken Lahti, SHL’s Chief Science and Innovation Officer, Yvette Cameron, Co-Founder and EVP of Velocity Career Labs, Lidiya Nadych-Petrenko, Global Head of Talent Attraction for JTI, Adeline Looi, the Global Head of Talent & Leadership for Nestle, and Tanya Delany, the Head of Global Assessments for Philip Morris International. This team will talk about the impact (anticipated gains, successes, and challenges) that the internet of careers has and will have on hiring and developing talent within large enterprises. They will discuss how this upcoming disruption changes how they create talent strategies, and the opportunity it brings for talent strategy to take a major role in board rooms.

This special Sydney Ideas conversation marks the 10th Annual Robert Dixon Memorial Animal Welfare Symposium and explores a series of critical questions regarding companion, performance and wild animals. Considering we don't euthanise humans, how do we navigate through the ethics of conduct in this space and the potential conflicts of interest? Our panel discuss factors that influence end-of-life decisions. FEAUTURING – Dr Larry Vogelnest - Senior Veterinarian, Taronga Conservation Society – Dr Martin F. Lenz, Queensland Racing Integrity Commission – Dr Emma Whiston, Veterinary Home Euthanasia Service – Dr Peter Bennett, Associate Professor in Oncology and Small Animal Medicine, University of Sydney – Dr Kat Littlewood, Lecturer in Animal Welfare, Massey University New Zealand – Chair: Dr Bidda Jones, Chief Science & Strategy Officer, RSPCA Australia For more information, visit the Sydney Ideas website: https://bit.ly/3k5rnqB

Energy is the lifeblood of our economy and culture. As legacy sources come under pressure from new technologies, how should we think about powering our society? What emerging trends will impact our future? Michael Webber has been thinking about these topics for decades. His most recent project was spearheading the production of "Power Trip: The Story of Energy," a multipart miniseries featured on PBS. He is the Chief Science and Technology Officer of Engie, a Paris-based energy and infrastructure company. Prior to that he was a tenured professor at UT Austin, where he was a prolific author and speaker.

  Tisha Schuller, Principal for Adamantine Energy, sits down with Michael Webber, Chief Science and Technology Officer for ENGIE—a Paris-headquartered global energy and infrastructure services firm to discuss the pivotal role for natural gas in the energy future. Webber is the author of the recent New York Times-acclaimed book, “Power Trip: The Story of Energy,” which has been adopted into a 6-part companion PBS mini-series aimed at educating youth on past, current, and future energy challenges. Based out of Austin, Texas, Webber concurrently holds the Josey Centennial Professorship in Energy Resources for the University of Texas-Austin. Webber is a renowned speaker on current and future energy affairs—testifying before the U.S. Senate and House of Representatives, addressing the United Nations and U.S. Military Academy at West Point, and giving keynote speeches for various scientific conferences and business symposiums. Webber holds dual undergraduate degrees from the University of Texas-Austin, a Master's degree in Mechanical Engineering from Stanford University, and a Ph.D. in Mechanical and Electrical Engineering from Stanford University. Episode Resources · “The Oil Industry is Part of the Solution”, Mechanical Engineering Magazine · Webber's book, “Power Trip: The Story of Energy” · PBS Mini-Series, “Power Trip: The Story of Energy” · Consider giving to Webber's group of students at UT-Austin, the Webber Energy Group Subscribe here for Tisha's weekly "Both Things Are True" email newsletter. Follow all things Adamantine Energy at www.energythinks.com. [Webinar originally recorded on June 17, 2020]  

  Tisha Schuller, Principal for Adamantine Energy, sits down with Michael Webber, Chief Science and Technology Officer for ENGIE—a Paris-headquartered global energy and infrastructure services firm to discuss the pivotal role for natural gas in the energy future. Webber is the author of the recent New York Times-acclaimed book, “Power Trip: The Story of Energy,” which has been adopted into a 6-part companion PBS mini-series aimed at educating youth on past, current, and future energy challenges. Based out of Austin, Texas, Webber concurrently holds the Josey Centennial Professorship in Energy Resources for the University of Texas-Austin. Webber is a renowned speaker on current and future energy affairs—testifying before the U.S. Senate and House of Representatives, addressing the United Nations and U.S. Military Academy at West Point, and giving keynote speeches for various scientific conferences and business symposiums. Webber holds dual undergraduate degrees from the University of Texas-Austin, a Master’s degree in Mechanical Engineering from Stanford University, and a Ph.D. in Mechanical and Electrical Engineering from Stanford University. Episode Resources · “The Oil Industry is Part of the Solution”, Mechanical Engineering Magazine · Webber’s book, “Power Trip: The Story of Energy” · PBS Mini-Series, “Power Trip: The Story of Energy” · Consider giving to Webber’s group of students at UT-Austin, the Webber Energy Group Subscribe here for Tisha's weekly "Both Things Are True" email newsletter. Follow all things Adamantine Energy at www.energythinks.com. [Webinar originally recorded on June 17, 2020]  

All episodes of the Podcast are on YouTube, Spotify, Apple Podcasts and all other major podcast distributors. A new episode is released every week.My guest this week is Mark Gooding, the Chief Science and Technology officer from Mirada Medical. Mark has worked with Mirada since the concept was born out of Oxford University during his tenure, and has been on an incredible healthcare technology journey with them ever since.We discuss the need for innovation in the industry, how they're able to stay ahead of the curve, working out of a tiny room in your house, and much more.You can find out more here:https://mirada-medical.com/And you can reach out to me here:https://www.linkedin.com/in/duncan-goldie-b2355193/Please subscribe to stay up to date with all the latest episodes and interviews with Digital Health leaders from around the world!

Brian Daly interviews RSPCA Australia’s Chief Science and Strategy Officer Dr Bidda Jones and Senior Policy Officer Dr Jed Goodfellow. In this episode, we delve into the RSPCA’s well-known and long-held opposition to live animal exports. For an organisation that supports farming and generally pushed to improve (rather than outright ban) poor practices – why is live export one of few exceptions? Dr Bidda Jones has been with the RSPCA for more than 20 years, and back then, the first report she ever wrote for the RSPCA was on the horrors of live sheep export to the Middle East. She’s also the author of Backlash: Australia’s conflict of values over live exports, which detailed the events leading up and beyond the notorious 2011 live export expose, A Bloody Business on the Australian ABC’s leading current affairs program, Four Corners. Dr Jones leads us through the strong case, the scientific knowledge and the overwhelming evidence that show live animal exports are risky, unnecessary and inherently bad for animal welfare. She also explains how animal welfare groups are generally responsible for any improvements in the trade, because the industry consistently fails to respond to issues or address animal welfare concerns without the public outrage of covert video evidence as a trigger. Dr Jed Goodfellow is the RSPCA Senior Policy Officer, an animal welfare lawyer and former RSPCA Inspector and prosecutor. He’s been working on the live export issue on behalf of the RSPCA for more than 9 years, and represents the RSPCA on a number of high-level government committee and industry groups. He talks about why the risks of live export are so difficult to mitigate. He outlines what conditions for animals are like on board live export ships, including their difficulty accessing food and water, as well as disease outbreaks and infections they’re likely to experience. He also talks about problems with the industry’s continuing focus on how many animals have died as a measure of animal welfare, and particularly, because this doesn't take account of thousands of animals that might suffer terribly but survive. Key points: Why the RSPCA is opposed to live animal exports: the scientific basis, the case against live exports, and the long history of repeated animal welfare disasters. Why live animal export is cruel and unnecessary when animals can be humanely slaughtered closer to home, boosting Australia's thriving trade in chilled and frozen meat to the same destinations. How both sheep and cattle exported can face horrific conditions on board, but these risks don’t end when the leave the ship, with multiple examples of terrible treatment in destination countries. How multiple government reviews conducted over decades have consistently found poor animal welfare is inherent to the trade and the business model, and that live export cannot be done humanely. Further links: ***Warning: These television programs feature graphic footage of animal cruelty in the live export industry, and viewers may find content this very distressing.*** ABC Four Corners: A Bloody Business: https://www.abc.net.au/4corners/a-bloody-business---2011/2841918 60 Minutes: Sheep, ships and videotape: https://9now.nine.com.au/60-minutes/sheep-ships-and-videotapes/5c6e8bce-b910-4287-87f7-2ac7fa5a80eb https://kb.rspca.org.au/article-categories/live-export/ Liveexport.rspca.org.au

Dr. Patrick H. Rice is currently the Chief Science & Research Officer (CSRO) and the Principal Investigator for Marine Research at Florida Keys Community College (FKCC).  Dr. Rice earned his Ph.D. (2008) in Marine Biology & Fisheries at the University of Miami.  His Ph.D. project was focused on reducing bycatch on longline boats.  With his business partner Dr. Eric Stroud they have worked on products to be used as chemical shark repellents. Capt Mike Puller is a 2nd generation charter fisherman from Miami.  Mike has been using the SharkTec Shark Repellent Chum that Dr. Rice has been working on and gives us a Fisherman’s perspective on the problem with sharks and this possible solution. You can learn more about Sharktec by visiting their website. This episode is brought to you by these great sponsors: Barracuda Tackle - Makers of the best cast nets on the market BarracudaTackle.com Get 30% off any order on Hukgear.com by using the code SE30 at checkout Get 20% off + free shipping on products from Manscaped.com by using the code TRP Kettle and Fire make Bone Broth that is Whole 30, Paleo and Keto Friendly.  It is made from Grass-fed and grass-finished beef bones, organic pasture-raised chicken and is Non-GMO.  It contains all the essential nutrients your body needs to thrive like collagen, protein, and amino acids.  Cooking your own is messy and time-consuming.  Go to Kettleandfire.com/waypoint to get yours delivered straight to your door. This episode has been brought to you by Waypoint TV. Waypoint is the ultimate outdoor network featuring streaming of full-length fishing and hunting television shows, short films and instructional content, a social media network, Podcast Network. Waypoint is available on Roku, Samsung Smart TV, Amazon Fire TV, Apple TV, Chromecast, Android TV, IoS devices, Android Devices and at www.waypointtv.com all for FREE! Join the Waypoint Army by following them on Instagram at the following accounts @waypointtv @waypointfish @waypointsalt @waypointboating @waypointhunt @waypointoutdoorcollective Find over 150 full episodes of Saltwater Experience on Waypoint You can follow Tom Rowland on Instagram @tom_rowland and find all episodes and show notes at Tomrowlandpodcast.com Learn more about Tom's Television shows by visiting their websites: Saltwater Experience Into the Blue Sweetwater Contact Tom through email: Podcast@saltwaterexperience.com Learn more about your ad choices. Visit megaphone.fm/adchoices

A global tour of energy – the builder of human civilization and also its greatest threat. Energy is humanity's single most important resource. In fact, as energy expert Dr. Michael E. Webber argues in Power Trip, the story of how societies rise can be told largely as the story of how they manage energy sources through time. In 2019, as we face down growing demand for and accumulating environmental impacts from energy, we are at a crossroads and the stakes are high. But history shows us that energy's great value is that it allows societies to reinvent themselves. Power Trip explores how energy has transformed societies of the past and offers wisdom for today's looming energy crisis. There is no magic bullet; energy advances always come with costs. Scientific innovation needs public support. Energy initiatives need to be tailored to individual societies. We must look for long-term solutions. Our current energy crisis is real, but it is solvable. We have the power. Michael is based in Paris, France where he serves as the Chief Science and Technology Officer at ENGIE, a global energy & infrastructure services company. Michael is also the Josey Centennial Professor in Energy Resources at the University of Texas at Austin. His expertise spans research and education at the convergence of engineering, policy, and commercialization on topics related to innovation, energy, and the environment. His latest book Power Trip: the Story of Energy was published May 7, 2019 by Basic Books with a 6-part companion series in development for PBS. His first book, Thirst for Power: Energy, Water and Human Survival, addressed the connection between earth's most valuable resources and offers a hopeful approach toward a sustainable future. Recorded 11 February 2020

Optimize your gut microbiome and health with personalized nutritional recommendations using VIOME microbiome testing. Dr Momchilo (Momo) Vuyisich is the Co-Founder and Chief Science officer of VIOME where they use AI to analyze your gut microbiome to make personalized nutritional recommendations that feed the good biochemical reactions in YOUR specific gut microbiome and limit negative biomechemical reactions of your gut microbiome to improve your gut microbiome and overall health.

In this episode, we continue our discussion with Dr. Bruce Bebo who is the Executive VP of Research for the National MS Society in part two of our two-part series. We explore the focus of research for the Society in 2020, “Pathways to Cures” and the road map for stopping, restoring, and ending MS! Dr. Bebo shares the importance of a lifestyle plan as well as more about the MS Navigator Program (accessible online, via email at ContactUsNMSS@nmss.org, or by calling 1-800-344-4867). For more information about the MS Navigator program, on-going research, and up-to-date information, visit the National Multiple Sclerosis Society; a site of information comprised of unbiased, fact-based, and reliable articles and resources.

In this episode, which is the first of a two-part series, we chat with Dr. Bruce Bebo the Executive VP of Research for the National MS Society. Dr. Bebo discusses his personal connection with MS as well Disease Modifying Therapies (DMT’s) and how far we’ve come in the last two decades. He also shares information on the outlook of medications in the pipeline and discusses funding for research studies.

In today's show I speak with Acumen Law's Kyla Lee about drinking while operating a horse & buggy as well as picking a song on your phone while stopped at a red light. I talk with Dr. Saskia Sivananthan who is the Chief Science & KTE Officer with the Alzheimer Society of Canada. January marks Alzheimer awareness month and there is also a new vaccine that could soon be tested on humans. And Blazers play-by-play announcer Jon Keen talks a pair of wins on the weekend as well as the upcoming WHL trade deadline.

This episode of Addicted to Fitness features an interview with fusion scientist, sleep hygiene expert, and Chief Science officer of Chili Products and the co-inventor of the ChiliPad, Tara Youngblood. Nick and Tara discuss how personal health issues inspired the creation of the ChiliPad, the importance of sleep quality over sleep quantity, and how regulating temperature while you sleep can lead to better sleep. If you're interested in learning more about Tara and Chili products visit chilitechnology.com. Like & Follow the Addicted to Fitness Podcast Facebook page (Facebook.com/addictedtofitnesspodcast). Make sure to check out our Shop page on addictedtofitnesspodcast.com to view ATF approved products from The Hemp & Coffee Exchange and Stick Mobility.

This is the first episode in a 4-part series sponsored by PMA! Bob Whitaker is the Chief Science & Technology Officer of the Produce Marketing Association. Bob has has a incredibly successful career, starting in the biotechnology plant space. He then spent time in the processing side of the produce industry before joining PMA over 10 years ago. In his role Bob has responsibility for food safety, technology, and issues leadership for the produce supply chain, from field to fork. Bob announced his retirement a few months ago and will be officially leaving after this year's Fresh Summit. He shares a ton of insight into the industry, including an emphasis on food safety and role of technology within agriculture. Tune in! Connect with PMA Website | Fresh Summit | Essentials of Food Safety Connect with The Modern Acre Website | Instagram | Twitter Sign up for Acre Insights HERE Join our Closed Facebook Group HERE

Energy is inherently related to every significant challenge of the 21st century: water scarcity, inequality, national security and agriculture. On this episode of Serving Up Science, Sheril Kirshenbaum speaks with Dr. Michael Webber, the Chief Science and Technology Officer at the global energy and infrastructure services company ENGIE.

Brian Daly interviews RSPCA Australia’s Chief Science and Strategy Officer, Dr Bidda Jones, to find out more about how farm animals are killed for food in Australia. In Australia, the killing of animals for food, fibre and other animal products (referred to as ‘slaughter’) is underpinned by minimal provisions in the Australian standard for the hygienic production and transport of meat and meat products for human consumption. The main objective of the standard is to ensure food safety, however, it also includes an animal welfare component.RSPCA Australia defines humane killing as when an animal is either killed instantly or instantaneously rendered insensible to pain until it dies. The Australian meat industry has developed its own National animal welfare standards for livestock processing establishments. By incorporating these standards into their quality assurance program (and standard operating procedures), abattoirs are able to demonstrate (to the state meat authority) that they meet regulatory requirements as well as better practice in terms of animal care and welfare.Standard procedures at Australian abattoirs are designed to hold and move animals throughout the facility in a calm, quiet and ‘low stress’ manner. Just prior to slaughter, animals are restrained and then stunned (rendered unconscious). Pre-slaughter stunning is scientifically recognised as essential for humane slaughter. Stunning ensures the animal is unconscious and insensible to pain before being bled out at slaughter.An operator should then confirm that each animal is unconscious and will be insensible to pain when the major blood vessels are severed shortly afterwards. The animal should not regain consciousness and no further processing should take place until the animal is confirmed dead.Key points:- The process of how farm animals are killed for food in Australia - What the legislation covers and how abattoirs operate - What stunning is and why it is important - Consumer questions around religious slaughter in Australia Further links:https://rspcaapproved.org.au/ https://kb.rspca.org.au/article-categories/slaughter/

Dr. K. invites the Chief Science and Clinical Officer Dr. Jeff Marksberry of Alpha Stim to join him to uncover the world of "electro-medical" products. Learn how sending a micro-current of electricity across your brain can help you with anxiety, insomnia and depression. Find out how the device works, when to use it, who it's intended for as well as why it was created. If you already have a sleep supplement stack, a mindfulness practice, mushroom coffees or any of the above, then you need to pay attention to this emerging technology.Interested in boosting your HRV, want to hack your meditation? Alpha-stim has both clinical indications and is now being introduced to the biohacking world as another option to help you feel better, sleep better and have more productive days.Support the show (https://www.instagram.com/sleepbiohacker/)

Did you know that you have not one, but TWO briains?  Your mind, and your gut.  That's the philosophy at Amare Global - the world's first Mental Wellness Company.  Find out how what you put in your body could be impacting your mental health, how you can control it, and how you can oftentimes manage your mental health by sometimes doing something as simple as adjusting your diet.  This episode I have a conversation with Chief Science officer and Founding Member of Amare Global for MentalHealthMonday.  Enjoy and happy Mental Health Awareness Month.  More info:  www.amare.com 

Did you know that you have not one, but TWO briains?  Your mind, and your gut.  That's the philosophy at Amare Global - the world's first Mental Wellness Company.  Find out how what you put in your body could be impacting your mental health, how you can control it, and how you can oftentimes manage your mental health by sometimes doing something as simple as adjusting your diet.  This episode I have a conversation with Chief Science officer and Founding Member of Amare Global for MentalHealthMonday.  Enjoy and happy Mental Health Awareness Month.  More info:  www.amare.com 

Neuroscientist Dr. Greg Gerdeman makes the scientific case for legalization and regulation.Interview content begins at 20:58.Greg Gerdeman, PhD was one of the first people to make me aware that the runner’s high is not the result of endorphins, but is in fact, brought on by endocannabinoids -- the molecules produced by our own bodies that mimic the effects of THC and CBD found in the plant. Since then, Greg, a former tenured professor at Eckerd College and now Chief Science officer at 3 Boys Farm, an organic greenhouse-based cannabis provider in Florida, has become a trusted friend and colleague. He is one of those rare people who can make complex biochemistry of cannabis understandable, even sexy.That's why Greg was the first person I called when I wanted to understand the difference between the scary synthetics like K2 or Spice and real cannabis. As he explains in this fascinating interview, these fake cannabinoids were first produced in labs by renown scientists who were looking to locate and understand the way that endocannabinoid system of receptors in our brains and bodies work. But unlike THC or CBD, the synthetics were designed to attach to stick to the receptors for a very long time. That’s why they are 10,000 more potent than natural cannabinoids and so much more dangerous.Even more dodgy are the haphazard ways they are made: Bad actors in Southeast Asia get access to these synthetic cannabinoids and then spray them on herbs in random, unknown quantities. Some doses may be mild; others deadly. No oversight = no quality control. They are exported are then sold here in gas stations and convenience stores to the uninformed looking for a cheap high. As Greg points out, this illicit trade is the result of prohibition. If everyone could legally obtain cannabis, the need for synthetic substitutes evaporates.In this wide ranging interview (which is reflective of Greg’s wide ranging brain) he also explains the differences between “full spectrum CBD” and CBD products made from “isolates” and “distillates.” He warns why the product labeled "organic" featuring a cute couple hiking The Rockies, might not be what’s advertised.To read all of Dr. Gerdeman's papers click here.

Cheap Home Grow had the pleasure of talking to Dr. Jahan Marcu. Dr. Marcu is the Chief Science officer for Americans for Safe Access. We talked about the endocannabinoid system and how cannabis can change the future of healthcare. Dr. Marcu shared his beliefs on how he sees the future of cannabis research playing out in the years to come. To suggest he’s optimistic about the health benefits of cannabis would be putting it lightly. I would also like to mention; he stressed more testing must be conducted before we know and understand the full potential of this plant medicine --- Support this podcast: https://anchor.fm/cheaphomegrow/support

Kevin Slavin is the Chief Science and Technology Officer of The Shed, which is an art center in New York that’s opening in 2019.Before The Shed, Kevin founded the Playful Systems group at MIT's Media Lab.He also gave a TED talk in 2011 called How Algorithms Shape Our World.The YC podcast is hosted by Craig Cannon.

Genevieve Graves, Co-Founder, Chief Science & Product Strategy Officer, hiQ Labs by Al Adamsen

Steve Swanson, co-founder of Vima, a sensory training technology company, is our guest for this Mountain Land Running Medicine Podcast. Steve has an extensive background in sports technology serving as Chief Science & Technology Officer for Athletic Republic, founder of Treadmetrix and AccuPower Solutions and the Inaugural Chair of Technology for the Sixth IOC World Congress on Sport Science.